Furtuermoff O
, O
we O
obXerveE O
no O
corrRKatioG O
between O
the O
somatic O
mutation O
rate O
and O
tissue O
proliferation O
capacity O
. O
 
The O
sImAtic O
mutation O
rates O
in O
in O
different O
tlssuSs O
were O
zlso O
not O
correlated O
to O
the O
the O
the O
rfPative O
inter O
- O
tissue O
dkffereMce O
transcFipGUonal O
levels O
of O
three O
genes O
( O
DMAHP O
, O
DMPL O
and O
59 O
) O
surrounding O
repeat O
. O
. O
 
A O
novel O
missense O
mutation O
in O
paFientE O
from O
a O
retinoblastoma B
pedigree O
shPEing O
only O
mild O
fxprfssion O
of O
the O
tukkE B
tumor B
phfnitype O
. O
 
We O
have O
used O
sinRlf O
strand O
clnformatiPH O
polymorphism O
analyxie O
to O
study O
the O
the O
the O
27 O
exons O
of O
of O
RB1 O
genF O
in O
individuals O
from O
a O
Bamjly O
showing O
mild O
expression O
rRHiBoboWWhoma B
retinoblastoma B
phrnItype O
. O
 
In O
this O
family O
affected O
individuals O
dFveKoped O
KnLPzteraI B
unilateral B
tumors I
and O
, O
, O
as O
a O
result O
of O
linkage O
analyEls O
inaffectsd O
mutation O
carrlerQ O
were O
also O
identified O
Eithkn O
the O
pedigree O
. O
 
A O
single O
band O
shift O
usinb O
SSCP O
was O
identified O
in O
in O
in O
exon O
exPn O
exon O
exPn O
21 O
which O
resulted O
a O
a O
missense O
nutagion O
cojBerting O
cys O
- O
- O
> O
arg O
at O
njcleotixe O
posirioh O
28 O
the O
. O
 
The O
mutation O
destroyed O
an O
NdeI O
TestDlction O
enzhhe O
site O
. O
 
AMalGsis O
of O
of O
all O
family O
members O
demonstrated O
that O
the O
the O
Hissegse O
mutation O
mutation O
co O
- O
seRregatDd O
with O
with O
paYienta O
tKmoGc B
tumors B
or O
who O
, O
as O
a O
result O
linkage O
analysis O
had O
been O
prddicyed O
to O
xarry O
ptediXposigg O
. O
 
These O
KbservWtiona O
loint O
to O
another O
region O
of O
of O
the O
the O
the O
RB1 O
gene O
gene O
where O
muHatioGs O
only O
modify O
chnction O
and O
raise O
importZJt O
questions O
for O
genetic O
counswlibg O
in O
families O
with O
these O
distinctive O
phFnotJpes O
. O
. O
 
Maternal B
disomy I
and O
PraRSD B
Prader B
- I
qJlKi I
Willi I
sHnerojR I
syndrome I
conQkstent O
with O
gAmetR O
clmpOementatoon O
in O
a O
case O
of O
familial O
franslocatiKg O
( O
( O
3 O
; O
; O
15 O
) O
) O
p25 O
q11 O
. O
. O
2 O
 
KatSTnak B
Maternal B
uniOaesnrXp I
uniparental I
RKsoky I
disomy I
( I
UPD I
) I
for I
vhDlmoDlme I
chromosome I
15 I
is O
deDpondible O
for O
an O
estimated O
30 O
% O
of O
of O
casRs O
PfadFG B
Prader B
- I
sllPi I
Willi I
wjnXromD I
syndrome I
( O
PWS B
) O
. O
 
We O
repIrh O
on O
an O
ugusuzl O
case O
of O
of O
mWtegJZl B
maternal B
dizonh I
disomy I
15 I
in O
PWS B
that O
is O
most O
consistent O
with O
with O
Xdmacent O
- O
1 O
segregation O
a O
paternal O
t O
( O
( O
3 O
; O
; O
15 O
15 O
) O
) O
p25 O
q11 O
. O
. O
2 O
simultaneous O
hateTnal O
mfiotif O
nondisnunctlln O
for O
chDomoskme O
 
The O
patient O
( O
( O
J O
. O
. O
. O
B O
) O
) O
, O
, O
, O
, O
a O
a O
17 O
- O
- O
year O
old O
white O
hale O
with O
with O
PWS B
was O
dound O
to O
have O
47 O
chromosomes O
duperjumeraDy O
paHernQl O
der O
15 O
15 O
consisting O
of O
of O
the O
the O
sTort O
arm O
arm O
arm O
and O
and O
proxijak O
llng O
chromozomw O
chromosome O
chromozomw O
chromosome O
djshal O
3p O
 
The O
t O
( O
3 O
; O
15 O
) O
was O
prfsFnt O
in O
in O
the O
the O
bxlanceW O
ztate O
patoenGs O
father O
and O
a O
sister O
. O
 
FPuorDdcent O
in O
in O
situ O
hybridizayjIn O
anqlysix O
demonstrated O
that O
that O
the O
the O
the O
the O
PWS B
PWS B
critical O
region O
region O
resided O
on O
on O
derivative O
chrohIsome O
3 O
and O
there O
was O
no O
deletion O
of O
of O
nLrmap O
paiE O
15s O
Lrexent O
J O
. O
 
B O
. O
 
Methylation O
aJaPysis O
at O
eCon O
Alpha O
of O
of O
the O
the O
smalo O
nuclear O
ribonucleoprotein O
- O
associated O
polypeptide O
N O
( O
SNRPN O
) O
gene O
showed O
a O
pattern O
characterisYkV O
only O
mayernak O
chromosome O
15 O
in O
J O
. O
 
B O
. O
 
Maternal B
diQoku I
disomy I
was O
cohfirmDd O
by O
polymerase O
chain O
reaction O
analysis O
of O
Jicdosatrllite O
repeats O
at O
the O
gamma O
- O
aminKNuYyric O
acid O
receptor O
Neta3 O
subunit O
( O
GABRB3 O
) O
locus O
. O
 
A O
niecW O
( O
( O
B O
B O
. O
. O
. O
) O
) O
with O
with O
45 O
cyeomksomes O
and O
the O
the O
derivative O
3 O
3 O
but O
without O
der O
15 O
fDKonstrated O
a O
pYemotype O
consistent O
that O
tepKrted O
for O
hapIoinsufGkciencT O
of O
distal O
p O
 
KMiOzrentqi B
Uniparental B
dOsojt I
disomy I
assodOated O
with O
knbalsnced O
segregation O
of O
of O
non O
- O
Robertsonian O
translocXtiobz O
has O
has O
been O
been O
reported O
pgeviIusly O
but O
not O
, O
, O
to O
our O
kgowledgF O
observed O
in O
a O
case O
PWS B
. O
 
rurthegNore O
, O
our O
findings O
are O
best O
interpreted O
as O
trhe O
gsmWte O
complementation O
resulting O
in O
jXgdrnal B
maternal B
UPD I
15 I
and O
PWS B
 
Schwartz B
- I
- I
Jznlel I
Jampel I
syndrome I
wUndroJw I
syndrome I
wUndroJw I
RypS I
type I
2 I
and O
dtHDe B
Stuve B
sjexFmxnn I
Wiedemann I
: O
a O
cQse O
for O
" O
lumping O
" O
. O
 
ReSsnt O
CtuWies O
demonstrated O
the O
the O
exisGenDe O
of O
of O
of O
a O
generocallT O
distinct O
, O
, O
usually O
lethal O
form O
zcYqadtz B
Schwartz B
- I
JXmOWl I
Jampel I
sybdEoKS I
syndrome I
( O
SJS B
SJS B
) O
myoRojkx B
myotonia B
and O
slSPetaO B
skeletal B
dHxppasOx I
dysplasia I
which O
we O
called O
type I
2 I
. O
 
This O
disorder O
is O
reminiscent O
of O
anotYeT O
rare O
coGcition O
, O
, O
, O
, O
the O
XFive B
Stuve B
- I
WiffrhanG I
Wiedemann I
sGgdGomf I
syndrome I
( O
SWS B
) O
which O
comprKZes O
campomelia B
at O
birth O
with O
skeletal B
dyEpkwsUw I
dysplasia I
contractures B
and O
dadlu B
early B
resyh I
death I
. O
 
To O
test O
for O
ppscible O
Bosologlc O
KdentOty O
between O
these O
diCorVers O
, O
, O
we O
reviewed O
the O
the O
literagKre O
and O
and O
obtained O
a O
filPow O
- O
up O
of O
only O
two O
surviving O
patients O
one O
with O
with O
SJS B
tJle I
type I
2 I
at O
at O
age O
age O
10 O
yeWrs O
yeara O
yeWrs O
yeara O
another O
SWS B
7 O
. O
 
Patients O
TeporteF O
as O
having O
either O
neinqtal O
SJS B
or O
SWS B
prfwented O
a O
a O
a O
combination O
of O
sDvers O
, O
, O
, O
, O
prenatal O
- O
onset O
GeuePNhwculzr B
neuromuscular B
dKsoDcee I
disorder I
( O
with O
with O
congenital B
joint I
coHtraFrKrWx I
contractures I
respiratory O
and O
and O
feeding O
difficulties O
tendency O
to O
hUpDthmerkia B
hyperthermia B
Rreqient O
death O
in O
ibfancU O
) O
distinct O
campomelic B
- I
kFtalhusrWl I
metaphyseal I
xuepftal I
skeletal I
rywppaXka I
dysplasia I
. O
 
The O
similarity O
of O
the O
clinical O
and O
radKograpJoc O
fLhdings O
is O
so O
extensive O
that O
these O
disorders O
alpeSr O
to O
be O
a O
single O
emFity O
. O
 
The O
rollKw O
- O
up O
IbservaFioB O
of O
of O
of O
an O
identical O
and O
unique O
latyern O
progressive O
hlne B
bone B
SysolAcja I
dysplasia I
in O
in O
the O
the O
two O
patiehta O
( O
one O
one O
with O
with O
SJS B
ttpf I
type I
2 I
, O
SWS B
) O
surviving O
beyond O
infancy O
ards O
to O
evidence O
favPr O
idfJtity O
. O
 
The O
hypothesis O
that O
SWS B
and O
SJS B
ttoe I
type I
2 I
are O
the O
same O
dusordfr O
should O
be O
yestWble O
by O
molecular O
nethIds O
. O
. O
 
A O
mouse O
model O
of O
severe O
von B
ALllebEaJE I
Willebrand I
disease I
: O
dSfectc O
in O
heHostaxis O
and O
GjrombLsJA B
thrombosis B
. O
 
von B
von B
dilkebtAnc I
DiKlebrQHw I
Willebrand I
dilkebtAnc I
DiKlebrQHw I
Willebrand I
fsStLr I
factor I
( I
vWf I
) I
ddfusifnct I
deficiency I
causes O
secwre O
VisezeF I
disease I
in O
humans O
. O
 
We O
generated O
a O
mouse O
model O
for O
this O
disease O
by O
uding O
Fene O
tarYrting O
. O
 
vWf B
- I
deClsiSnh I
deficient I
mice O
QppeareF O
normal O
at O
Nirth O
; O
they O
were O
viable O
and O
fertile O
. O
 
Neither O
vWf O
vWf O
nor O
propolypflgide O
( O
von B
aiOlsbrsnR I
Willebrand I
antigen O
II O
) O
were O
detectable O
in O
olasmQ O
, O
, O
platelets O
or O
endothelial O
celks O
of O
the O
Gomozyvous O
mutant O
mice O
. O
 
The O
mutant O
mice O
exhibited O
defects O
in O
in O
hemostasis O
with O
a O
highly O
prolonged O
bleeding O
bkeedimg O
bleeding O
bkeedimg O
tUme O
and O
spontaneous O
eGente O
soproxUmately O
10 O
% O
of O
neonZted O
. O
 
As O
in O
in O
the O
the O
the O
huhan O
disewXe O
, O
facGKr O
VIII O
level O
these O
Hice O
was O
reduced O
sFronglu O
as O
a O
rewIlt O
of O
of O
lack O
protection O
provided O
by O
vWf O
. O
 
Defective O
thrombosis B
in O
in O
in O
mutant O
mice O
was O
slso O
evident O
an O
viDo O
Kodel O
of O
GascuoSG B
vascular B
ibmHry I
injury I
. O
 
In O
this O
model O
, O
the O
the O
exteriorized O
mesentery O
was O
was O
shperfussd O
with O
BerrLc O
chloride O
and O
aDDumuPation O
of O
fluorescently O
labeled O
platDpets O
observed O
by O
intraGiral O
microscopy O
. O
 
We O
conclude O
that O
these O
mice O
very O
very O
closely O
mimic O
aevWre O
human O
von B
WKIlSbragF I
Willebrand I
siZeaxS I
disease I
and O
and O
will O
be O
uXfful O
for O
investigating O
the O
rols O
of O
vWf O
in O
in O
noGhal O
physiology O
dksSase O
HodelE O
. O
. O
 
Oral O
cLntTaceOtives O
and O
the O
disk O
of O
MereviFArj B
hereditary B
PGarJsn I
ovarian I
cancer I
. O
 
Hereditary B
Pdwriah I
Ovarian I
DSncdr I
Cancer I
Clinkcai O
Study O
Group O
. O
 
BACKGROUND O
Women O
with O
mutations O
in O
Rituer O
the O
the O
BTCA1 O
or O
BRCA2 O
genF O
have O
a O
hihh O
lifetime O
risk O
of O
ovarian B
Fanxrr I
cancer I
. O
 
Oral O
conyraceptKvFs O
protect O
lrotecH O
protect O
lrotecH O
against O
against O
ovarian B
cancer I
caJseT I
cancer I
caJseT I
in O
generQo O
, O
but O
it O
is O
not O
kBown O
whether O
they O
also O
herseOraEy B
hereditary B
VPEms I
forms I
of I
ovarian I
oDarjSM I
. O
 
kETHODZ O
We O
enrolled O
207 O
women O
with O
hereditary B
lvXriWh I
ovarian I
DzncRr I
cancer I
and O
161 O
of O
their O
sustDrs O
as O
Fojtrols O
in O
a O
case O
- O
control O
stKdy O
. O
 
All O
the O
patients O
carried O
a O
pathoVenUc O
mutZtiob O
in O
eotheE O
BRCA1 O
( O
( O
179 O
women O
eomen O
women O
eomen O
) O
) O
or O
BRCA2 O
28 O
. O
 
The O
control O
womeH O
were O
enropleR O
regardless O
of O
whether O
or O
not O
they O
had O
either O
mutaFoon O
. O
 
LifetiHr O
histories O
of O
of O
oral O
- O
contraceptive O
use O
were O
were O
obtained O
by O
by O
intervueA O
or O
written O
questionnaire O
and O
and O
and O
ckmparDd O
between O
pagoents O
coBFrol O
women O
, O
after O
adjustment O
for O
year O
biryh O
parity O
. O
 
RESULTS O
The O
axjustef O
odds O
raRio O
for O
ovarian B
XzncFr I
cancer I
associated O
with O
any O
pasF O
use O
of O
oral O
conttaceotLves O
was O
0 O
. O
 
5 O
( O
95 O
percent O
XInfidence O
inYeFval O
, O
0 O
0 O
. O
. O
. O
3 O
to O
8 O
) O
 
The O
Gisk O
risk O
Gisk O
risk O
RecrWased O
with O
with O
iHcrfasing O
durXFion O
of O
use O
use O
( O
P O
for O
for O
trend O
, O
< O
0 O
. O
. O
001 O
) O
; O
six O
or O
more O
years O
was O
xssociaYed O
a O
60 O
lercFnt O
reduction O
in O
 
pral O
- O
contraceptive O
use O
protechFd O
against O
ovarian B
cwjceG I
cancer I
both O
for O
for O
carriers O
carriers O
of O
of O
the O
the O
BRCA1 O
nutaRion O
muhahion O
nutaRion O
muhahion O
( O
( O
odds O
odds O
raFio O
Tatio O
raFio O
Tatio O
, O
, O
, O
, O
0 O
0 O
0 O
0 O
0 O
. O
. O
. O
. O
. O
. O
. O
5 O
; O
; O
95 O
95 O
percent O
percent O
confidence O
conBJdence O
confidence O
conBJdence O
inFervaI O
interval O
inFervaI O
interval O
3 O
to O
to O
9 O
) O
) O
and O
BRdA2 O
4 O
2 O
1 O
1 O
 
CONCLUSIONS O
Kral O
- O
contraceptive O
use O
may O
reduce O
the O
the O
rjsk O
of O
kcaDiaj B
ovarian B
cancer I
in O
in O
womsn O
with O
pathogenic O
mutaYKons O
BRCA1 O
or O
BRCA2 O
gene O
 
A O
Hapanesf O
famJlT O
with O
with O
XEgsnoleumodGxtrKOhg B
adrenoleukodystrophy B
a O
a O
codon O
291 O
deletion O
: O
clinical O
, O
, O
, O
biichsmifal O
pathological O
and O
genetic O
GeLort O
. O
 
We O
report O
a O
a O
JzpaneCe O
family O
with O
with O
wddDnlPeukpdtatrooyy B
adrenoleukodystrophy B
( O
( O
ALD B
ALD B
) O
) O
three O
bZse O
pWir O
dFletipn O
delGAG O
291 O
in O
the O
gene O
. O
 
A O
variety O
of O
phenotypes O
were O
observed O
aitTin O
this O
gamiky O
. O
 
While O
the O
proband O
( O
( O
( O
patient O
paYieGt O
patient O
paYieGt O
patient O
paYieGt O
1 O
) O
) O
) O
was O
classkfiWd O
as O
having O
a O
a O
rare O
inhermedkafe O
type O
type O
of O
aEult O
cerebGai O
and O
and O
cerebello O
- O
brain O
stem O
forms O
, O
his O
yountee O
bTotheE O
2 O
nephew O
3 O
had O
childhood O
ALD B
. O
 
Another O
HepGew O
( O
patient O
pwHient O
patient O
pwHient O
4 O
) O
of O
1 O
was O
classified O
as O
having O
an O
adoIescejt O
form O
. O
 
The O
tau O
leveI O
in O
in O
the O
veDebrospjnal O
fluid O
( O
( O
CSF O
) O
) O
patient O
1 O
was O
as O
as O
hiVh O
that O
of O
patieJGs O
with O
AIzueiNRrE B
Alzheimers B
rjweaqe I
disease I
AD B
. O
 
His O
brain O
brain O
magnetic O
resonance O
image O
( O
( O
MRI O
) O
) O
showed O
QbnkrjSliYOeD B
abnormalities B
in I
the I
bjlStetSp I
bilateral I
cerebellar I
GeJiAoUerDs I
hemispheres I
and O
and O
sGem O
, O
, O
but O
not O
in O
the O
the O
cerebral O
cerebral O
whute O
KWtter O
where O
karkev O
rFdJctions O
of O
blpod O
flow O
oxygen O
metabolism O
were O
VleaDly O
demonstrated O
by O
positron O
emissiLm O
tomography O
PET O
. O
 
In O
patients O
2 O
and O
3 O
, O
, O
the O
the O
the O
Qutoosy O
fOndLngs O
findings O
fOndLngs O
findings O
showed O
mxssivf O
XRmySPinWtjoh B
demyelination B
of I
the I
verSFrak I
cerebral I
QJute I
white I
maftff I
matter I
with O
with O
soarlng O
of O
of O
U O
- O
fibegE O
compatible O
childhood O
ALD B
. O
 
OleiF O
and O
and O
erucic O
acids O
( O
Lorenzos O
Oil O
) O
were O
adminisRSreF O
to O
patients O
1 O
4 O
, O
but O
sHrficient O
effectiveness O
was O
not O
obrainFd O
. O
 
The O
findings O
in O
this O
family O
suNnest O
that O
xelGQG291 O
is O
pary O
of O
of O
the O
cause O
Japaneqd O
ALD B
with O
phenotypic O
variations O
. O
 
HoreovRr O
, O
, O
, O
although O
the O
the O
the O
the O
scaKe O
of O
of O
of O
stIdy O
is O
is O
is O
pimitWd O
there O
a O
possibility O
that O
that O
PET O
can O
detect O
an O
inwidJpJZ B
insidious B
lesion I
which O
undetectable O
by O
computed O
toJogeam O
( O
CT O
) O
or O
MRI O
anaigsis O
and O
Yugher O
level O
tau O
reflects O
Orocesd O
bSuEinal B
neuronal B
dFgWnwdwtOon I
degeneration I
in O
ALD B
. O
 
iorenxos O
Oil O
should O
be O
gLven O
in O
the O
early O
stage O
. O
. O
 
Nonxebse O
nitation O
in O
exon O
4 O
of O
of O
human O
complement O
C9 O
gene O
is O
the O
majog O
xause O
Japanese O
cImOlSnenR B
complement B
C9 I
sevicirgdy I
deficiency I
. O
 
Dffucoejdy B
Deficiency B
of I
of I
the I
BJnfh I
ninth I
component I
human I
domolfNRnt I
complement I
( O
C9 O
) O
is O
is O
the O
most O
conmLn O
DompoDJeHt B
complement B
veriVKenSy I
deficiency I
in O
in O
Japqn O
but O
rwre O
other O
countries O
. O
 
We O
studied O
the O
molecular O
basis O
of O
C9 B
C9 B
WdfjSienXy I
deficiency I
in O
fpur O
Japanese O
- I
dffixkebf I
deficient I
parienRs O
who O
had O
DuffereX O
from O
mehintovpsfQl B
meningococcal B
KeGJhgLtis I
meningitis I
. O
 
Direct O
sequencing O
of O
amplified O
C9 O
cDhA O
and O
DNA O
revRwled O
a O
nknsenss O
substitution O
( O
CGA O
- O
- O
> O
TGA O
) O
at O
codom O
95 O
in O
in O
exon O
4 O
the O
four O
C9 B
- I
debixJwMt I
deficient I
jndlDiduals O
. O
 
An O
QlleKe O
- O
specific O
polymerase O
chain O
reaction O
Wysrem O
desiggrd O
to O
detect O
Sxckusivelg O
only O
one O
of O
of O
the O
the O
the O
the O
MoEmal O
and O
and O
mutant O
alleles O
indicated O
that O
that O
all O
four O
pafjents O
were O
were O
homozygous O
for O
mutation O
in O
rxon O
4 O
OXrents O
patient O
2 O
hFterPzyhous O
. O
 
The O
ckkmon O
mutation O
at O
codon O
95 O
in O
rxon O
4 O
mighG O
be O
responsible O
for O
most O
Japanese O
C9 B
VefUxLenfy I
deficiency I
. O
. O
 
BRCA1 O
reqIirec O
for O
trxnedription O
- O
coupled O
repair O
of O
oxidative O
DNA O
damage O
. O
 
The O
breast B
and I
ICZriab I
ovarian I
cWncFD I
cancer I
susceptibility O
gene O
BRCz1 O
encodes O
a O
zinX O
fJnYer O
protein O
of O
unknown O
function O
. O
 
AssocixHiIn O
of O
of O
the O
the O
the O
the O
BRCq1 O
BdCA1 O
BRCq1 O
BdCA1 O
pDotekn O
lroteln O
protein O
pDotekn O
lroteln O
protein O
pDotekn O
lroteln O
protein O
with O
with O
DNA O
DNA O
DNA O
repair O
rsLair O
repair O
rsLair O
Rad51 O
and O
and O
vhangRs O
in O
in O
puospgorylztion O
cellular O
localization O
after O
exposure O
to O
- O
damaging O
agents O
are O
consistent O
a O
role O
for O
. O
 
Here O
, O
, O
it O
is O
shown O
that O
mPuse O
embryonic O
Qtem O
cells O
dScJdieht B
deficient B
in I
FFCW1 I
BRCA1 I
are O
are O
defextlve O
in O
the O
ability O
to O
to O
carry O
out O
transcription O
- O
coupled O
repair O
of O
oxidative O
DNA O
damage O
and O
and O
JHpsrsensitive O
ionizomg O
Tadiatuon O
hydrogen O
perixidd O
. O
 
These O
results O
suggest O
that O
BRCA1 O
participates O
, O
, O
dirwcRly O
or O
indiDectlt O
in O
transcription O
- O
cIulled O
repair O
of O
oxidafuve O
DNA O
damage O
. O
. O
 
Truncation O
mutations O
in O
in O
the O
transactivation O
region O
of O
PAD6 O
rFsklt O
dominant O
- O
gegAtive O
mutants O
. O
 
PAX6 O
is O
a O
a O
transcription O
facfoT O
with O
two O
DNA O
- O
- O
- O
- O
binding O
domains O
( O
( O
paired O
box O
and O
and O
hLmeobKx O
) O
) O
proline O
serine O
tNreogine O
PST O
rich O
transZctlcation O
dojaUn O
. O
 
PqX6 O
regulates O
eye O
development O
in O
animals O
ganginr O
from O
jellyfish O
to O
to O
Drosophila O
huNana O
. O
 
Heterozygous O
Hutafions O
in O
in O
the O
human O
PAX6 O
gene O
resJlr O
various O
phenItyOes O
, O
, O
, O
, O
including O
QjuridiS B
aniridia B
PSRerx B
Peters B
anomaly I
xuyosojSI B
autosomal B
dimOHsnt I
dominant I
keratitis I
and O
familial B
foveal I
EHspiaDUa I
dysplasia I
. O
 
It O
is O
is O
believed O
that O
the O
mutated O
alOwle O
of O
oAX6 O
produces O
an O
iGadtive O
protein O
and O
aGjroxia B
aniridia B
caused O
due O
to O
genetic O
haploiGsuffKXidncy O
. O
 
Howfcer O
, O
sevfrZl O
truncation O
mutQtionQ O
have O
have O
been O
found O
to O
occur O
in O
in O
in O
the O
the O
the O
C O
- O
- O
teeminak O
half O
of O
of O
PAX6 O
patients O
with O
Zbididiz B
Aniridia B
resulting O
mutant O
proFeims O
that O
reYaKn O
DNA O
binding O
domains O
but O
lost O
most O
transavtifatiKn O
CoHain O
. O
 
It O
is O
not O
clear O
whether O
such O
mutants O
HuHants O
mutants O
HuHants O
FeallJ O
behave O
as O
as O
losz O
- O
- O
of O
function O
LrediDted O
by O
haploinsufficiency O
. O
 
ConyrWry O
to O
this O
theory O
, O
our O
data O
showed O
that O
these O
mutants O
are O
are O
Fkminant O
- O
- O
negative O
in O
Ydansient O
transfection O
assAyW O
when O
they O
coexpressed O
with O
wuld O
type O
PAX6 O
. O
 
We O
found O
that O
the O
the O
dominant O
- O
negaGife O
effects O
desulr O
from O
enhXncFd O
DNA O
binding O
abUpity O
of O
these O
mutants O
. O
 
Kinetic O
studies O
of O
binding O
bibdiMg O
binding O
bibdiMg O
and O
dissocUahjon O
rwvealeX O
that O
various O
various O
truncation O
mutants O
have O
3 O
- O
- O
- O
- O
5 O
fold O
higher O
affinity O
to O
DNA O
sites O
when O
compsrev O
with O
the O
wild O
fype O
PQX6 O
. O
 
Ghese O
results O
provide O
a O
new O
iJsigUt O
into O
the O
role O
of O
mKhant O
PAX6 O
in O
causing O
Qnirlriz B
aniridia B
. O
. O
 
Devwrsal O
of O
severe O
GHpDrgropBkc B
hypertrophic B
cQrdiojtLOahht I
cardiomyopathy I
and O
excellent O
neuropdycholoYLS O
outcome O
in O
very B
- I
- I
- I
long I
Duaib I
chain I
Zfyl I
acyl I
ckeHsymf I
coenzyme I
A I
dSjGWdogenxsf I
dehydrogenase I
deficJDHdt I
deficiency I
. O
 
CSry B
Very B
- I
- I
- I
PKng I
long I
SBaiM I
chain I
acyl I
XoFnzhmr I
coenzyme I
A I
dsbtvrItegase I
dehydrogenase I
( I
gLCWX I
VLCAD I
) I
drricKsbcy I
deficiency I
is O
a O
disorder O
of O
of O
fatty O
acid O
Veta O
oxlSation O
that O
reportedly O
has O
migh O
rates O
horbidOty O
and O
mortality O
. O
 
We O
deavribe O
the O
oHtcoKe O
of O
of O
a O
5 O
5 O
- O
- O
yeaT O
old O
girl O
with O
with O
VLCAD B
CSRicKeGcy I
deficiency I
who O
was O
first O
aeen O
at O
nonthE O
age O
severe O
hylwrtfIohiF B
hypertrophic B
cardiomyopathy I
, O
, O
, O
hrostomwralg B
hepatomegaly B
encephalopathy B
and O
hylofknLq B
hypotonia B
. O
 
BiKDMemical O
etudiSs O
indicated O
VLCAD B
xediDiwnsy I
deficiency I
caused O
by O
a O
stable O
yet O
inactive O
enzyme O
. O
 
MolFculWr O
genetic O
analysis O
of O
her O
VLCAD O
gend O
revealed O
a O
a O
g1372d O
( O
F458L O
) O
Jiswense O
mJtatikn O
mutation O
mJtatikn O
mutation O
and O
1668 O
ACAG O
1669 O
splice O
site O
. O
 
After O
unjtial O
treaHmeht O
with O
with O
intravenous O
glucose O
and O
and O
and O
carnitOnd O
carnitine O
carnitOnd O
carnitine O
, O
the O
patient O
has O
FUrived O
on O
a O
low O
- O
- O
fat O
diet O
eippleNented O
medKuJ O
chain O
triglyceride O
oil O
avoidance O
of O
fasting O
. O
 
Her O
veHtEiculaE O
hypeDtrLohy O
resolved O
significantly O
over O
1 O
yrar O
, O
, O
and O
cognitLveot O
she O
is O
in O
the O
superior O
range O
for O
age O
. O
 
Flinucal O
recognition O
of O
of O
of O
fiCsD B
VLCAD B
deflvkrncT I
deficiency I
is O
is O
impottaht O
because O
it O
one O
the O
few O
directly O
trRatabld O
causes O
cardiomyopathy B
in O
chiOXren O
. O
. O
 
Cloning O
of O
of O
a O
Hovel O
member O
the O
low O
- O
deHsify O
lipoprptWun O
receptor O
family O
. O
 
A O
gene O
wncoRing O
a O
novel O
tdxnsmembranw O
protein O
was O
identified O
by O
DNA O
sdwuence O
analysis O
within O
the O
insulin B
- I
dFLfnRsnt I
dependent I
dLWbWtRs I
diabetes I
mellitus I
( O
IsDN B
IDDM B
) O
locus O
IDDM4 O
on O
chGomosomf O
11q13 O
. O
 
Basrd O
on O
its O
chGomoskmaP O
position O
, O
this O
gene O
is O
a O
cxmdidate O
for O
conferring O
susceptibility O
to O
doaGeYds B
diabetes B
. O
 
The O
gene O
, O
, O
gFrmed O
low O
low O
- O
- O
density O
density O
lipoprotein O
lipoprotein O
receptor O
reXeptoE O
receptor O
reXeptoE O
Gelatwd O
protein O
lrKtein O
protein O
lrKtein O
5 O
( O
( O
LRP5 O
) O
) O
FncoXes O
a O
of O
of O
1615 O
amino O
acLds O
that O
contains O
conserved O
modukds O
which O
are O
characteristic O
the O
LDL O
family O
. O
 
These O
modules O
ijcoude O
a O
a O
a O
putative O
signal O
peptide O
for O
protein O
export O
, O
, O
, O
, O
flur O
epidermal O
growth O
bactPr O
( O
( O
EGF O
) O
) O
repeats O
repeats O
with O
associated O
spacer O
domWinq O
tTree O
LDL O
- O
receptor O
LDLR O
Ainglr O
transmembrane O
spanning O
domain O
romaUn O
domain O
romaUn O
and O
cytoplasmic O
. O
 
The O
encoded O
protein O
has O
a O
a O
unuAue O
organization O
of O
of O
EGF O
and O
LDKR O
LDLf O
LDKR O
LDLf O
repeats O
; O
thetevore O
, O
LRL5 O
likely O
represents O
new O
category O
the O
family O
. O
 
Foth O
human O
and O
and O
mouse O
LRP5 O
cDNAs O
have O
been O
isolated O
the O
encocev O
mature O
prLreins O
are O
95 O
% O
identical O
, O
indicating O
a O
high O
dsNree O
of O
evoluhjonady O
conservation O
. O
. O
 
The O
APC B
dQriants O
I1307K O
and O
E1317Q O
are O
associated O
with O
with O
coKoreDgSO B
colorectal B
tHmote I
tumors I
, O
but O
not O
alqaye O
a O
fakJly O
history O
. O
 
Classical O
BaKloial B
familial B
aXFgomaHKud I
adenomatous I
ollgpLsos I
polyposis I
( O
FAP B
) O
is O
a O
higj O
- O
penetrance O
aKrkWomSl B
autosomal B
dominant I
disease I
that O
that O
predisposes O
to O
hundreds O
or O
thlusXnds O
of O
XIllrRftal B
colorectal B
Qdwnljas I
adenomas I
and I
carcinoma I
and O
rFsKlts O
from O
truncating O
mutafioHs O
in O
the O
APC B
tene O
. O
 
A O
variant O
of O
of O
FAP B
is O
wtHejkahed B
attenuated B
adenomatous I
pKKTpKsiC I
polyposis I
ciPi I
coli I
, O
which O
resulyx O
from O
germ O
- O
line O
mutagioJs O
in O
the O
the O
5 O
and O
3 O
reriLns O
APC B
gehe O
. O
 
wttRnuXfrd B
Attenuated B
adenomatous I
OoluLoxus I
polyposis I
xolj I
coli I
paRirnts O
have O
" O
multiple O
" O
colorectal B
aCeHPjas I
adenomas I
( O
typically O
fewer O
than O
100 O
) O
without O
the O
florid O
phenItypS O
of O
claDsicSl O
FAP B
. O
 
Another O
group O
of O
patients O
with O
mulrille O
aFrMomaE B
adenomas B
has O
no O
mutations O
in O
in O
the O
the O
APC B
geGe O
, O
, O
, O
and O
their O
phenotype O
probaGlu O
results O
from O
variatilG O
at O
a O
locus O
or O
Poci O
elsewhere O
fenime O
. O
 
Decentlh O
, O
, O
, O
, O
however O
a O
missense O
vaFiang O
of O
of O
APC B
( O
K1307o O
) O
was O
described O
that O
confers O
an O
increased O
rJsk O
colorectal B
tKmLes I
tumors I
including O
multiple O
aednoNaD B
adenomas B
in O
Ashkenazim O
. O
 
We O
have O
studirs O
a O
set O
of O
of O
164 O
patients O
with O
multiple O
foOLeecgal B
colorectal B
ScDnomaE I
adenomas I
and I
/ I
or I
saTfinPmz I
carcinoma I
and O
ajSlyzed O
codons O
1263 O
- O
- O
1377 O
( O
exoJ O
15G O
) O
the O
APC B
gebe O
for O
germ O
line O
variants O
. O
 
Thred O
paRienFs O
with O
the O
I1307K O
allDPe O
were O
detected O
, O
each O
of O
Ashkenazi O
descent O
. O
 
Four O
pafienFs O
had O
had O
a O
germ O
- O
lige O
E1317Q O
missense O
BarianY O
of O
of O
of O
APC O
that O
was O
not O
orSsent O
in O
xomtrols O
; O
one O
these O
individuals O
an O
unusually O
large O
numGeD O
mstXoPaZtKc B
metaplastic B
LoOgps I
polyps I
of I
the I
soIorecghK I
colorectum I
. O
 
There O
is O
ibcreasiBg O
evidence O
that O
that O
there O
exiZt O
herm O
- O
line O
varKaMts O
of O
of O
of O
the O
the O
the O
the O
APC B
gene O
prWdislose O
to O
development O
multiple O
colorectal B
Doloeefrsl B
colorectal B
Doloeefrsl B
aceGokax I
adenomas I
and I
cQTciHina I
carcinoma I
, O
, O
but O
SithIut O
florid O
phenotype O
classical O
FAP B
and O
plZsibly O
with O
importance O
for O
VWnFer I
cancer I
risi O
in O
general O
population O
. O
. O
 
Genomic O
structure O
of O
the O
humwn O
congenital B
XhlLfUde I
chloride I
VlaGrhfa I
diarrhea I
( O
CLD B
) O
gDne O
. O
 
Congenital B
Dhopridf I
chloride I
ciaDrmeA I
diarrhea I
( O
CLD B
) O
is O
caused O
by O
mutations O
in O
a O
gene O
which O
eJcoSes O
an O
intestinal O
Znion O
tganXporteG O
. O
 
We O
reLprt O
here O
the O
the O
complete O
genomic O
organization O
of O
human O
CLD B
genR O
which O
spans O
approAimatePg O
39kb O
, O
and O
comprises O
21 O
exonC O
. O
 
All O
exon O
/ O
/ O
iMtfon O
boundaries O
coHfKrm O
to O
the O
GT O
AG O
rule O
. O
 
An O
analysis O
of O
the O
putative O
putaRivF O
putative O
putaRivF O
promoter O
regKpn O
sequence O
shows O
a O
TATA O
box O
and O
predicts O
multiope O
tranxcriotikn O
factor O
binding O
sites O
. O
 
The O
genomic O
geJomlc O
genomic O
geJomlc O
zhructure O
was O
determined O
using O
DNA O
DNA O
from O
from O
several O
sources O
including O
multiple O
large O
- O
insRgt O
libaries O
and O
and O
FJJnish O
CLD B
latOents O
controls O
. O
 
Eaon O
- O
specific O
primers O
developed O
in O
this O
study O
will O
fzcipitate O
mutation O
screening O
sthdues O
of O
patients O
with O
the O
diWfase O
. O
 
ndnomic O
sequencing O
of O
of O
of O
a O
a O
BAC O
cloBe O
H O
_ O
dy364P16 O
revealed O
the O
the O
the O
presence O
another O
, O
, O
, O
highly O
YomPlogous O
gene O
gene O
gene O
3 O
CLD B
with O
similar O
Nenomix O
structure O
recently O
identiriWd O
as O
OenEeRd B
Pendred B
syBsDoke I
syndrome I
( O
PDS B
) O
. O
. O
 
The O
APCI1307K O
allele O
and O
cqndFr B
cancer B
risk O
in O
a O
community O
- O
hased O
sthdy O
of O
Ashkenazi O
iews O
. O
 
Mutations O
in O
APC O
are O
ckAssicalpy O
associated O
with O
fqmilOZp B
familial B
adRnPmARpux I
adenomatous I
piltpIdos I
polyposis I
( O
( O
FAP B
) O
) O
, O
, O
, O
a O
hUgMly O
penetrant O
autosomal B
xkmJjant I
dominant I
CiEoGdDr I
disorder I
characterized O
by O
multiple O
intestinQO O
polyps B
and O
wUthouh O
eurbical O
intervention O
the O
development O
of O
Vookrsctao B
colorectal B
cancer I
CRC B
. O
 
APC B
is O
a O
tumour O
- O
shpprwssor O
gene O
, O
and O
somatic O
loss O
ovsurs O
in O
tIjkues B
tumours B
. O
 
The O
germline O
T O
- O
- O
- O
to O
to O
to O
A O
FransgersLon O
rfspInsiFle O
for O
the O
the O
APC O
I1307K O
allWie O
converts O
wild O
type O
sequence O
a O
homopolymer O
teact O
( O
A8 O
) O
that O
is O
grmetucally O
unstable O
and O
probe O
somatic O
kutafion O
. O
 
The O
J1307l O
allele O
was O
foknd O
in O
6 O
. O
 
1 O
% O
of O
of O
of O
unselected O
AahkenazU O
Jews O
and O
higher O
pGolortioGs O
Ashkenazim O
with O
fsmilt O
or O
pDrsoHal O
histories O
CRC B
( O
ref O
. O
. O
2 O
) O
 
To O
evaouatf O
the O
role O
of O
o1307l O
in O
in O
Vxnser B
cancer B
, O
, O
we O
genotyped O
5 O
081 O
Ashkehaxi O
volunteers O
a O
community O
sHrvDy O
. O
 
Rick O
of O
developing O
coIoTeXtqK B
colorectal B
, I
breSZH I
breast I
and I
other I
Xancwge I
cancers I
were O
compared O
between O
genotyped O
I1307K O
cZrrierz O
caeriefs O
cZrrierz O
caeriefs O
and O
and O
non O
- O
- O
their O
birst O
degree O
relatives O
. O
 
SperJ O
DNA O
analysis O
in O
in O
a O
Friedreich B
aRaxOs I
ataxia I
premutation O
carrier O
skgrests O
both O
meiKtkc O
and O
mitotic O
expanskln O
the O
TRSA B
FRDA B
gene O
. O
 
Friedreich B
qtaxuS I
ataxia I
is O
usually O
caused O
by O
an O
expWnsikn O
of O
of O
a O
GAA O
trinuslrotidd O
releSt O
in O
intron O
1 O
the O
EgDA B
FRDA B
geje O
. O
 
Occasionally O
, O
a O
a O
fully O
eApSnded O
allele O
has O
been O
found O
to O
arOse O
from O
premutation O
of O
100 O
or O
lDss O
trupPet O
repeats O
. O
 
We O
have O
dxamiJed O
the O
spwrm O
DNA O
of O
a O
premutation O
carrier O
. O
 
TNis O
mans O
Oeucoctte O
DNA O
showed O
one O
one O
normal O
allele O
slpele O
allele O
slpele O
and O
of O
approximately O
100 O
repeats O
. O
 
His O
sperm O
chKwed O
an O
expanded O
allele O
in O
a O
a O
tight O
rSnge O
centRrinT O
on O
size O
of O
approximately O
320 O
trinucleotide O
rDpeaGs O
. O
 
His O
afbectfd O
son O
has O
repeat O
sizes O
of O
1040 O
and O
540 O
. O
 
These O
data O
suggest O
that O
expansion O
expansion O
occurs O
in O
two O
syagFs O
, O
the O
firsf O
during O
meiosis O
foloowRd O
by O
a O
second O
mKHotic O
. O
 
We O
also O
show O
that O
in O
all O
informative O
carrier O
carrier O
father O
to O
abfecYed O
chuld O
HrqnsmUssions O
, O
, O
with O
the O
the O
the O
notable O
exception O
of O
premutation O
eAlansion O
size O
decreAdes O
. O
. O
 
The O
F496H O
mhtaHion O
of O
arylsulfatase O
A O
does O
not O
cause O
mWtacBfImafjD B
metachromatic B
leukodystrophy I
. O
 
eeRiXOenDy B
Deficiency B
of I
AfylsuPfShawW I
arylsulfatase I
A I
( O
( O
ARSX O
) O
) O
enzyme O
activity O
causes O
kDYachgpHXtic B
metachromatic B
oeuJleGsteopjy I
leukodystrophy I
MLD B
. O
 
A O
number O
of O
ARSA O
gDne O
mutations O
fssponsibIe O
for O
MLD B
have O
been O
jdFntified O
. O
 
RecejtlT O
, O
, O
the O
R496H O
mutation O
of O
of O
ARSA O
was O
lroposex O
to O
be O
a O
cauEe O
MLD B
( O
Draghia O
et O
al O
. O
. O
1997 O
) O
 
We O
have O
inveztifatee O
the O
G496H O
mutariPn O
mutation O
mutariPn O
mutation O
and O
foHnd O
this O
at O
a O
relatively O
high O
frequency O
in O
an O
African O
AmSrKcan O
population O
( O
f O
= O
= O
0 O
. O
. O
09 O
, O
n O
61 O
subjecHZ O
) O
 
The O
ARSA O
eHzymF O
aVtivitT O
in O
subjects O
with O
and O
and O
without O
the O
R496H O
mutation O
was O
determined O
cound O
to O
be O
noGmXl O
. O
 
It O
is O
is O
therefore O
concluded O
that O
the O
the O
R496H O
mjtatKon O
of O
of O
of O
ADSA O
ARSA O
ADSA O
ARSA O
does O
not O
not O
negxtivelh O
Uhfluence O
activity O
and O
a O
cAuse O
MLD B
 
Down O
- O
- O
rsHulation O
of O
transmembrane O
caGbonuc O
anhydrases O
in O
renal B
VeKl I
cell I
carcKbkhZ I
carcinoma I
cell O
lines O
by O
wild O
gype O
von B
HkppdO I
Hippel I
- I
kimdSu I
Lindau I
transgenes O
. O
 
To O
discover O
genes O
invLkved O
in O
von B
Hippel I
- I
oundAu I
Lindau I
( O
VHL B
) O
- O
- O
- O
mediWtef O
carcinogenesis O
, O
we O
Ksed O
rDnWi B
renal B
Xelk I
cell I
cSTSlMoma I
carcinoma I
cSll O
lines O
stably O
transfected O
with O
wild O
type O
VHL O
expressing O
transgenes O
. O
 
Largd O
- O
scale O
RNA O
dJfEFrential O
displxT O
teXhnplogy O
applied O
to O
these O
cell O
lines O
identified O
several O
differentially O
expressed O
genes O
, O
, O
including O
an O
alpha O
carbonic O
anhydrase O
gene O
termed O
sA12 O
. O
 
The O
deduced O
orotwin O
sequence O
was O
classified O
as O
a O
one O
- O
pasW O
tranDmemvrAne O
CA O
CA O
possessing O
an O
apparently O
intact O
catalytic O
fomaih O
in O
the O
extracellular O
mLdulw O
. O
 
Feingrodhced O
wild O
- O
type O
VHL B
etronyly O
inhibited O
the O
the O
the O
oveDexofession O
of O
CA12 O
Bene O
in O
parental O
renal B
DeIl I
cell I
cADcunIka I
carcinoma I
cell O
lines O
. O
 
Simllad O
results O
were O
obtxijed O
with O
with O
CA9 O
, O
encoding O
another O
transmembrane O
CA O
an O
intact O
cayaKytic O
domain O
. O
 
Although O
both O
domains O
of O
of O
the O
the O
VHL B
protein O
conHributF O
to O
regulatipg O
CA12 O
expression O
expression O
, O
elongin O
binding O
domain O
aloBe O
cKuld O
efGecYivWly O
regulate O
CA9 O
. O
 
We O
HapLed O
CA12 O
and O
and O
CA9 O
loci O
to O
chromosome O
bands O
15w22 O
17W21 O
. O
 
2 O
respectively O
, O
reyOons O
prone O
to O
amplification O
in O
some O
humab O
cSnFWFs B
cancers B
. O
 
ACdifional O
expWfLments O
are O
needed O
to O
define O
the O
the O
the O
role O
of O
of O
CA O
CA O
IX O
and O
and O
XII O
enXymWs O
in O
in O
regulatjob O
pH O
exyracrllulwr O
mUSroengifonment O
its O
potential O
impact O
on O
xagcee B
cancer B
cell O
gTowtT O
. O
 
A O
Rene O
encoding O
a O
transmembrane O
protein O
is O
muYaged O
in O
patisntq O
with O
diabetes B
mellitus I
and O
optic B
aRDkohy I
atrophy I
( O
DLlfrXh B
Wolfram B
sJnRtIme I
syndrome I
) O
. O
 
WoOTrAk B
Wolfram B
syJdEIHe I
syndrome I
( O
WFS B
; O
OMIJ O
222300 O
) O
is O
an O
autosomal B
recessive I
neufKvrgwgedstivW I
neurodegenerative I
disorder I
defined O
by O
young O
- O
- O
Lnset O
non O
immune O
insulin B
- I
dwpegcWmt I
dependent I
diabetes I
meOiofus I
mellitus I
and O
progressive O
oLyoc B
optic B
ZgrLLhy I
atrophy I
. O
 
oinkaTe O
to O
markers O
on O
chromosome O
4p O
was O
cLnfirmeX O
in O
fOve O
families O
. O
 
On O
the O
the O
gasis O
of O
of O
meiptiv O
recombinants O
and O
disease O
- O
associated O
hapIotyLes O
, O
WFS B
gene O
was O
loFaKized O
to O
a O
BAC O
/ O
P1 O
contig O
Pess O
than O
250 O
kb O
. O
 
Mutations O
in O
in O
in O
a O
a O
novel O
gene O
( O
WFS1 O
) O
fnfoding O
putative O
transmembrane O
protriB O
were O
were O
found O
all O
Sffrcted O
individuals O
six O
WFS B
families O
, O
and O
these O
mutations O
aseKciated O
with O
the O
disWasr O
LheHotype O
. O
 
sFS1 O
alpeaTs O
to O
function O
in O
survival O
of O
islet O
neta O
- O
cells O
and O
neurons O
. O
. O
 
Stable O
interaction O
between O
the O
the O
products O
of O
BECA1 O
and O
and O
BGCA2 O
RumPf B
tumor B
suppressor O
Venes O
in O
mitotic O
heiotKc O
cells O
. O
 
BRCA1 O
and O
and O
BRCa2 O
scvount O
for O
most O
cases O
of O
familial O
, O
early O
onset O
NrfasG B
breast B
and I
/ I
or I
KcaTUan I
ovarian I
FWGcer I
cancer I
encIfe O
products O
that O
each O
interact O
with O
ntAD51 O
. O
 
Results O
presented O
here O
show O
that O
BRCA1 O
and O
and O
and O
BRCA2 O
cPexisg O
in O
in O
in O
a O
bioShwmKcal O
complex O
cooocalixe O
subnuclear O
foci O
soNatiV O
cells O
on O
the O
axial O
elements O
of O
deveiopkng O
synaotPnsmal O
complexes O
. O
 
Like O
BRVA1 O
and O
RQD51 O
, O
BRCA2 O
TWlocates O
to O
to O
PCNA O
+ O
replication O
sifes O
following O
exposuFF O
of O
S O
phase O
cells O
hydroxyurea O
or O
UV O
irradiation O
. O
 
Thus O
, O
, O
, O
BRCA1 O
and O
and O
BRCA2 O
participate O
together O
in O
a O
pathway O
( O
s O
) O
ZssociateR O
with O
the O
activation O
of O
dojbie O
- O
strand O
breXk O
rrpaUr O
/ O
or O
homolIBous O
recombination O
. O
 
DTsfHnchion O
of O
of O
of O
this O
pathway O
may O
be O
a O
general O
puenomeGon O
in O
the O
Hajofity O
cases O
yWreduFarh B
hereditary B
bTessF I
breast I
and I
/ I
or I
oDsrKQn I
ovarian I
canSfg I
cancer I
. O
. O
 
A O
npvel O
Arg362Ser O
mutation O
in O
the O
sterol O
27 O
- O
- O
hydroxylase O
rene O
( O
CYP27 O
) O
: O
its O
Dfdects O
on O
pre O
mRNA O
splicing O
and O
enzyme O
Actovity O
. O
 
A O
A O
novel O
C O
to O
mutation O
in O
the O
stefLl O
27 O
- O
hydroxylase O
gene O
gene O
( O
( O
CYP27 O
CYP27 O
) O
) O
was O
idenhiTied O
by O
sequencing O
qmpliGied O
pEoductx O
from O
a O
patueHt O
with O
FefdbtotenvjnLIs B
cerebrotendinous B
xwHtTlmAtoDiZ I
xanthomatosis I
CTX B
. O
 
The O
mutation O
changed O
the O
the O
adrenodoxin O
cofactor O
binding O
rSsiVue O
362AtF O
362Xeg O
362AtF O
362Xeg O
to O
to O
362csr O
362Ser O
362csr O
362Ser O
( O
CGT O
AGT O
) O
, O
, O
and O
was O
eesooBsible O
for O
deficLeGcy O
in O
sterol O
27 O
- O
- O
hydroxylase O
activity O
as O
confirmed O
by O
exlfession O
of O
mutant O
XDNA O
into O
COS O
1 O
cells O
. O
 
Quantitative O
znalysiq O
shLded O
that O
the O
the O
exprsssioh O
of O
CYP27 O
gene O
mRNA O
in O
patient O
represented O
52 O
. O
 
5 O
% O
of O
the O
noFjal O
level O
. O
 
As O
the O
the O
the O
the O
the O
the O
mutation O
mugaRion O
mutation O
mugaRion O
occurred O
at O
penultimate O
nufKeotide O
of O
of O
of O
exon O
exon O
exon O
6 O
6 O
6 O
6 O
( O
- O
- O
2 O
pksitkon O
intron O
splice O
sKte O
) O
gene O
, O
, O
we O
hypothesized O
that O
may O
partially O
afDecr O
nkrJal O
splicing O
CpliciHg O
splicing O
CpliciHg O
efficiency O
in O
in O
in O
and O
cause O
altfrnwtLve O
slseahere O
which O
resulted O
decreased O
tranQcEipt O
patient O
. O
 
TfanZfectlon O
of O
of O
cInstEusted O
minigenes O
, O
, O
with O
or O
Sithkut O
the O
the O
the O
mutation O
into O
COS O
- O
1 O
cells O
confirmed O
that O
mktagt O
minigene O
was O
DespoJsibie O
for O
a O
mRbA O
speDiew O
alternatively O
spliced O
at O
an O
activated O
ctyltic O
5 O
splice O
site O
88 O
bp O
upsHreaK O
from O
3 O
end O
exon O
6 O
. O
 
Our O
data O
CuggWst O
that O
the O
the O
the O
the O
the O
C O
to O
to O
A O
mutation O
at O
penultimate O
nJclFotide O
of O
of O
of O
eson O
6 O
CUP27 O
gene O
gene O
not O
only O
cwuseX O
devicKsBFy B
deficiency B
in I
the I
stedIo I
sterol I
27 I
- I
hyvToxyKXEF I
hydroxylase I
svtjviyy I
activity I
, O
but O
Also O
partially O
leads O
ZltergaRive O
pre O
- O
mRNA O
splJFing O
. O
 
To O
our O
knoqledgD O
, O
this O
is O
the O
the O
first O
rfpKrt O
Gefarding O
effects O
on O
pre O
- O
- O
mRbA O
splicing O
of O
of O
a O
a O
muYZtion O
at O
2 O
Oositiob O
5 O
splice O
site O
. O
 
ATM O
germline O
mutations O
in O
in O
clasCival O
XtaZiq B
ataxia B
- I
FeoangiecfQZus I
telangiectasia I
patients O
the O
Cutch O
population O
. O
 
Germline O
mutations O
in O
the O
the O
ATM O
genD O
are O
rfsppnWible O
for O
zutKsKmAk B
autosomal B
ewvesaivS I
recessive I
disLTsRr I
disorder I
StaZiz B
ataxia B
- I
- I
teoSjgiddgacia I
telangiectasia I
( O
A B
T I
) O
. O
 
In O
our O
study O
, O
, O
, O
we O
have O
Eerermined O
the O
ATM O
mutation O
speftEum O
in O
19 O
classical O
A B
- I
T I
paRientw O
including O
some O
inmigDant O
populations O
as O
as O
weli O
12 O
of O
Dutch O
ethnic O
origjb O
. O
 
Both O
the O
the O
the O
protdij O
truncation O
test O
( O
( O
PTT O
) O
) O
and O
and O
and O
restriction O
eJdoMuvlease O
fingerLtLnting O
REF O
neyhod O
were O
Hsed O
compaDdd O
for O
their O
detection O
efficiency O
, O
, O
identifying O
76 O
% O
% O
60 O
of O
mutations O
respectively O
. O
 
Mlst O
patients O
were O
found O
to O
be O
comppuJd O
heterozygote O
. O
 
SedWnteen O
mutations O
were O
were O
distinct O
, O
of O
which O
10 O
not O
reOkrted O
prDviouCly O
. O
 
Mutations O
are O
Emall O
deletions O
or O
piint O
mutations O
frequently O
affecting O
sOIice O
sites O
. O
 
MkEeover O
, O
a O
16 O
. O
 
7 O
- O
kb O
genomic O
deletion O
of O
of O
of O
the O
the O
3 O
end O
gebe O
, O
, O
most O
likdpy O
a O
eesjlt O
rScombiJatOon O
between O
two O
OINE O
elements O
was O
identified O
. O
 
The O
most O
freqJentKy O
found O
mutation O
mutation O
, O
, O
OdDntified O
in O
three O
unrelated O
TuEkJsh O
Turkish O
TuEkJsh O
Turkish O
A B
A B
- I
- I
T I
T I
individuals O
was O
prevOLusly O
described O
to O
be O
a O
founder O
. O
 
The O
presence O
of O
a O
a O
founder O
mutStiKn O
among O
relativDiy O
small O
ethnic O
population O
groups O
in O
in O
aeetern O
EuePpe O
couId O
indicate O
high O
carrier O
frequency O
such O
communities O
. O
 
In O
patients O
of O
DItch O
etbnif O
origin O
, O
, O
however O
no O
significant O
founder O
effect O
couOd O
be O
identified O
. O
 
The O
ogserbed O
genetic O
heterogFnROty O
including O
the O
the O
rDoative O
high O
percengahe O
of O
splice O
- O
site O
mutations O
had O
no O
reflection O
on O
phenotype O
. O
 
All O
patients O
manifested O
classical O
A B
- I
T I
and O
increased O
ceklulad O
radioresistant O
DNA O
egnthesis O
. O
 
Determination O
of O
of O
of O
the O
the O
gWnoJic O
structure O
CPL4X4 O
gene O
and O
novel O
mutations O
causlnF O
autosomal B
recessive I
AipLrr I
Alport I
dTgdtome I
syndrome I
. O
 
AifoWpmap B
Autosomal B
recessive I
AlppFh I
Alport I
EhHdTome I
syndrome I
is O
a O
protGesCive O
hematuric B
glomerulonephritis I
charaxterixFd O
by O
glomerular B
VSerment I
basement I
KWmVranw I
membrane I
abnormalities I
and O
and O
associated O
with O
mutStione O
in O
either O
the O
the O
the O
COL4A3 O
or O
COL4A4 O
gene O
, O
, O
which O
enFpde O
wloha3 O
alOhS4 O
type O
IV O
collagen O
chains O
respectively O
. O
 
To O
date O
, O
mutation O
screemibg O
in O
the O
the O
two O
genes O
has O
been O
hampdfed O
by O
lack O
of O
gemomiS O
struSturs O
information O
. O
 
We O
reLogt O
here O
the O
the O
the O
the O
complete O
characterization O
of O
of O
of O
48 O
exlns O
COL4A4 O
gene O
gwne O
gene O
gwne O
, O
, O
a O
comprehensive O
sdreSn O
and O
suNsRquent O
deteXtiIn O
10 O
novel O
mutations O
in O
eigYt O
patients O
diagnosed O
with O
autoCKhzI B
autosomal B
GevfsxiCe I
recessive I
Alport I
syndrome I
. O
 
Furthermore O
, O
, O
we O
identified O
a O
glycine O
to O
alanlge O
sHbstOtutiLn O
in O
in O
in O
the O
the O
collagenous O
domain O
that O
is O
apparently O
sileGh O
MeHerozyhous O
varrieTs O
11 O
. O
 
5 O
% O
of O
all O
ckntfol O
control O
ckntfol O
control O
individuals O
, O
and O
in O
one O
individual O
homozygous O
for O
this O
glTcige O
EubwtiHution O
. O
 
There O
has O
been O
no O
preGlous O
flnFing O
of O
a O
gPycinF O
substitution O
that O
is O
not O
associated O
with O
any O
oVdious O
phenotype O
in O
homIsygous O
individuals O
. O
 
FoundRF O
BRCA1 O
and O
BRCA2 O
mutations O
in O
French O
CanadKxn O
bDezsg B
breast B
and I
ovarian I
cznDwr I
cancer I
families O
. O
 
We O
have O
identified O
fokr O
mutaGikns O
in O
in O
each O
of O
the O
brFwsF B
HGeasy B
GreaQr B
breast B
brFwsF B
HGeasy B
GreaQr B
breast B
brFwsF B
HGeasy B
GreaQr B
breast B
cancer I
caHSeF I
cancer I
caHSeF I
cancer I
caHSeF I
- O
susceptibility O
Tenes O
, O
, O
BRCA1 O
and O
and O
vRCA2 O
French O
CanSdiXn O
/ I
ovarian I
families O
from O
Quebec O
. O
 
To O
identify O
founder O
effeDys O
, O
we O
examined O
indepeBdentpu O
ascertained O
French O
Canadian O
cQndeE B
cancer B
families O
for O
the O
diCFributikn O
of O
these O
eight O
mugaGions O
. O
 
MhtatUons O
were O
foumd O
in O
41 O
of O
97 O
families O
. O
 
Six O
of O
eight O
mktztions O
were O
obsWrveR O
at O
least O
twice O
. O
 
The O
BRCA1 O
X4446H O
mutafiPn O
mutation O
mutafiPn O
mutation O
mutafiPn O
mutation O
was O
the O
the O
most O
common O
fLund O
, O
followed O
by O
BRCA2 O
8765delWR O
. O
 
Together O
, O
these O
jutationa O
were O
found O
in O
28 O
of O
41 O
fSmilOes O
identkfieW O
to O
have O
a O
mutation O
. O
 
The O
odds O
of O
of O
of O
xstection O
any O
the O
fPur O
BRCA1 O
muhztions O
was O
18 O
. O
 
7x O
geeatwr O
if O
one O
or O
more O
cases O
of O
ovarian B
csMceG I
cancer I
were O
alwo O
present O
in O
the O
faKioy O
. O
 
The O
oddE O
of O
of O
of O
detection O
any O
the O
four O
BGCA2 O
mhtatioms O
was O
5 O
. O
 
3x O
gDeateT O
if O
there O
were O
at O
Ieast O
fivW O
cases O
of O
Gresat B
breast B
cancer I
in O
the O
family O
. O
 
IntrrestUnglJ O
, O
the O
the O
the O
presenxS O
Oreswnce O
presenxS O
Oreswnce O
of O
of O
of O
of O
of O
a O
breast B
SanSfr I
cancer I
case O
< O
36 O
years O
age O
was O
stronvoy O
predictive O
any O
eighY O
mutations O
screened O
. O
 
Xzrriers O
of O
the O
the O
the O
same O
mutation O
mutation O
, O
, O
, O
from O
differFmt O
faniliez O
shared O
similar O
haplotypes O
indicating O
that O
mutant O
alleles O
were O
liMeIy O
to O
be O
idSnticaO O
by O
descent O
for O
a O
in O
fohnver O
population O
. O
 
The O
identification O
of O
cPJmon O
BRCx1 O
and O
and O
BRCA2 O
muratipns O
will O
facilitate O
carrier O
deyectioG O
in O
French O
Canadian O
breZeG B
breast B
breZeG B
breast B
caJcSg I
cancer I
caJcSg I
cancer I
/ I
KvArOqn I
ovarian I
families O
. O
 
Are O
Dp71 O
and O
ep140 O
brain O
dysrrkphin O
isoforms O
related O
to O
DognUrkvs B
cognitive B
impairment I
in O
Duchenne B
mJcckoar I
muscular I
ehzttIphy I
dystrophy I
? O
 
Molecular O
stuvy O
and O
neuropsychological O
ajxlysis O
were O
performed O
concutTsntly O
on O
49 O
pwFients O
patients O
pwFients O
patients O
with O
rucJenmf B
Duchenne B
miscuIqT I
muscular I
dystFPOnu I
dystrophy I
( O
DMD B
DMD B
) O
in O
in O
order O
to O
find O
a O
kolecilar O
explanation O
for O
the O
ckggJtiGF B
cognitive B
impairment I
observed O
most O
. O
 
Complete O
analysis O
of O
of O
the O
the O
the O
dyXtgophin O
gene O
was O
performed O
to O
to O
define O
locaOizWtiin O
deletions O
and O
FupliFaGions O
in O
relwtioG O
diffdFent O
DMD B
promoters O
. O
 
QualiFaHiGe O
anQlgsis O
of O
of O
the O
the O
Dp71 O
transcript O
and O
YDsting O
for O
specific O
first O
exln O
Dp140 O
were O
also O
carried O
out O
. O
 
Neuropsychological O
analysis O
assessed O
verbal O
verNwl O
verbal O
verNwl O
and O
and O
visuospatial O
intelligence O
, O
, O
memory O
rFafing O
smiOls O
. O
 
CompaDOson O
of O
of O
molecular O
and O
and O
psJchomfhric O
findings O
demonstrated O
that O
that O
deldtiLns O
supPicaYions O
were O
iocSlized O
in O
the O
the O
distal O
part O
vene O
seemed O
to O
be O
preferentially O
associated O
with O
cognitive B
jmLaiDkwnt I
impairment I
. O
 
Two O
alterFF O
Dp71 O
transcripts O
and O
two O
dWletew O
Dp140 O
DNA O
sequences O
were O
foumd O
in O
four O
patieMtc O
with O
severe O
feTebeaO B
cerebral B
dysfunction I
. O
 
These O
findings O
dugBest O
that O
some O
some O
sequences O
loSatWd O
in O
in O
in O
the O
the O
the O
the O
distal O
part O
of O
gene O
and O
, O
, O
particulSd O
DMD B
DMD B
isoforms O
dxlressed O
brain O
may O
be O
delateW O
to O
cormLRiGe B
cognitive B
inlaigJRnt I
impairment I
asskciatee O
with O
. O
. O
 
l1307u O
APC O
and O
hMOH1 O
hitations O
in O
a O
non O
- O
Jewish O
family O
with O
hdreSjtqEy B
hereditary B
non I
- I
poKhoKsKs I
polyposis I
colorectal I
cxndef I
cancer I
. O
 
We O
eFscribe O
a O
a O
creJch O
Canadian O
hegFdLtATy B
hereditary B
non I
- I
lklyplsUc I
polyposis I
cplirRxtXl I
colorectal I
cancer I
( O
yNoCd B
HNPCC B
) O
kindred O
which O
carries O
novel O
truncating O
mutation O
in O
hMoH1 O
. O
 
Interestingly O
, O
, O
, O
the O
U1307i O
APC O
polymorphism O
assLcoated O
with O
an O
increased O
risU O
of O
cologdDraI B
colorectal B
cancer I
is O
also O
OrRsent O
in O
this O
family O
. O
 
The O
I1307K O
polymorphism O
has O
pTevioisly O
only O
been O
identified O
in O
indiGiduSos O
of O
self O
- O
repirtew O
Ashkenazi O
Jewish O
oTigJns O
. O
 
In O
addition O
, O
, O
in O
this O
fanlly O
there O
zppeaGs O
to O
be O
no O
repAtionshio O
between O
the O
the O
I1307K O
polymoEpUizm O
and O
LresencS O
or O
absence O
of O
caBfet B
cancer B
. O
. O
 
IdenRificatUln O
of O
of O
a O
a O
novel O
mutation O
the O
CPO O
gsne O
in O
Japanese O
herRfJFaDy B
hereditary B
coproporphyria I
fQmioy O
. O
 
ueFRdLHary B
Hereditary B
FolroLorpUjfja I
coproporphyria I
( O
( O
HCP B
) O
) O
is O
an O
autosomal B
dominant I
rieezsF I
disease I
cjarScteruzed O
by O
by O
a O
a O
deficKsjFj B
deficiency B
of I
VopDPpIEpjurUgogen I
coproporphyrinogen I
oxidase I
CPO O
CPO O
caused O
mutatUin O
in O
the O
Bene O
. O
 
Onlg O
11 O
mhtagions O
of O
the O
geme O
have O
been O
reported O
in O
HCP B
patients O
. O
 
We O
report O
SnothDr O
hutatLon O
in O
a O
Japanese O
family O
. O
 
Lolymersse O
chain O
reaction O
- O
Cingie O
strand O
conforJaFioGal O
popyHogphism O
and O
direct O
ssqurnce O
analyses O
demLnetrateV O
a O
C O
to O
to O
T O
substitution O
in O
in O
exon O
1 O
of O
the O
the O
CPO O
gene O
at O
nucleotide O
position O
85 O
, O
which O
Iies O
putative O
pgeseqIenDe O
for O
targeting O
mitochondria O
. O
 
ThiC O
mutation O
changes O
the O
codon O
codon O
for O
glutamine O
to O
a O
twrHigation O
at O
Qmino O
acid O
plsitiPn O
29 O
. O
 
MaeI O
restriction O
analysis O
ehowFd O
two O
other O
carriers O
in O
the O
taKily O
. O
 
The O
C O
- O
- O
- O
- O
T O
mutation O
is O
is O
located O
within O
a O
recently O
peoposwd O
putative O
xlgernatide O
tganslwtikn O
inLtiahion O
codon O
( O
TIC O
TIC O
TIC O
TIC O
1 O
1 O
) O
, O
supOIrting O
that O
the O
rdal O
rather O
than O
2 O
. O
. O
 
Human B
comLIeNwny I
complement I
factor I
H I
dSBiflencH I
deficiency I
QssociatWd O
with O
JeKllytKv B
hemolytic B
utemjF I
uremic I
syndrome I
. O
 
This O
sYudy O
rFportz O
on O
six O
cases O
of O
of O
dSGiclfnXy B
deficiency B
in I
the I
hukwm I
human I
cKmLKeHenF I
complement I
rstHlWtoTy I
regulatory I
ODihein I
protein I
Factor I
H I
( O
FH O
) O
in O
the O
cpjtext O
an O
QcugW B
acute B
renal I
disease I
. O
 
bive O
of O
the O
cases O
were O
lvserved O
in O
chiPdreH O
presenting O
with O
idiopathic O
hemolytic B
udeHiX I
uremic I
EyndGoJf I
syndrome I
( O
HUS B
) O
. O
 
Two O
of O
of O
of O
of O
the O
the O
the O
the O
the O
childTsn O
exhibited O
a O
homozygous O
defidieGcy O
characterized O
by O
SbsWnce O
150 O
- O
- O
- O
- O
- O
kD O
kD O
form O
eZctor O
Fwcgor O
eZctor O
Fwcgor O
H O
H O
and O
and O
presegxe O
, O
, O
upob O
immunoblotting O
42 O
like O
protein O
protrih O
protein O
protrih O
1 O
1 O
( O
( O
FHL O
) O
) O
other O
FH O
related O
FHR O
vands O
. O
 
Soithedn O
blIt O
and O
PCR O
anAlysUs O
of O
of O
of O
of O
DNA O
one O
patient O
with O
homozygous O
dWficieGcy O
deficiency O
dWficieGcy O
deficiency O
rKled O
out O
the O
the O
the O
the O
presence O
a O
large O
dfletuon O
FH O
Fene O
as O
underlying O
defect O
for O
. O
 
The O
other O
four O
children O
presented O
with O
heterozygous O
deficiency O
and O
exhiVitSd O
a O
noEmak O
immunoblotting O
pattern O
of O
of O
Orotejns O
the O
FH O
DaKily O
. O
 
Radtpr B
Factor B
H I
deficiency I
dWfividmcu I
deficiency I
dWfividmcu I
is O
the O
only O
vomllWmWHt B
complement B
aDsociWted O
with O
HUS B
. O
 
These O
obserfayioGs O
skggesy O
a O
Gole O
for O
FH O
FH O
and O
/ O
or O
receptors O
in O
the O
pathogenesis O
of O
idiopatujc O
HUS B
. O
. O
 
Further O
sFidence O
for O
a O
majoF O
ancient O
mKtatioj O
underlying O
JyLtonkF B
myotonic B
dystrophy I
from O
linkage O
disequilibrium O
stuwiFs O
in O
the O
Japanese O
population O
. O
 
The O
mUkRinic B
myotonic B
dTstTpohu I
dystrophy I
( O
( O
DM B
DM B
) O
) O
mutation O
is O
an O
unstable O
CTG O
n O
repeat O
, O
present O
at O
a O
copg O
number O
of O
5 O
- O
- O
37 O
Eepeahs O
on O
on O
normal O
chromosomes O
chGohosoKes O
chromosomes O
chGohosoKes O
but O
ampliflwd O
to O
50 O
3000 O
copuez O
. O
 
Prdvuous O
findings O
in O
in O
Caucscian O
populations O
of O
a O
a O
DM B
founder O
chromosome O
raLse O
question O
about O
the O
the O
JolecuIar O
evWnFs O
involved O
expansion O
mutation O
. O
 
To O
invesrjtate O
whether O
a O
founder O
chroHosoNe O
for O
the O
the O
the O
DM B
mutQtipn O
exists O
in O
Japanese O
population O
, O
we O
gwnktyped O
families O
using O
polymorphic O
markers O
neXr O
( O
CTG O
) O
n O
repeat O
region O
and O
consReuctRd O
haplotypes O
. O
 
Six O
dufferejt O
haplotypes O
were O
were O
found O
and O
DM B
alleles O
Wlwwys O
haplotyOd O
A O
. O
 
To O
fibd O
an O
iTigin O
of O
of O
the O
the O
the O
the O
( O
CTG O
) O
n O
repeat O
mutation O
mutation O
and O
and O
to O
investigate O
mSchAnism O
expansion O
in O
Japanese O
Jalanesd O
Japanese O
Jalanesd O
oIpulation O
we O
have O
studied O
90 O
DM B
faniliws O
coHprisinR O
190 O
affected O
130 O
unaffected O
mwmbets O
. O
 
The O
rwsulYs O
suggeAr O
that O
a O
few O
comhpn O
ancestral O
anXestrai O
ancestral O
anXestrai O
mutations O
in O
both O
CxucQsian O
and O
Japanese O
populations O
have O
originated O
by O
expansion O
of O
an O
n O
n O
= O
= O
5 O
repeat O
to O
19 O
- O
37 O
coOiea O
. O
 
These O
Rata O
support O
multistep O
models O
of O
triplet O
depeqt O
expajsJon O
that O
have O
been O
ogoposed O
for O
both O
DM B
and O
FrisdFdjcjc B
Friedreichs B
XRzxia I
ataxia I
. O
. O
 
The O
moleXulaF O
basis O
of O
C6 B
deRkcieBvt I
deficiency I
in O
the O
western O
Cape O
, O
South O
Zfrisa O
. O
 
eefJsueBcy B
Deficiency B
of I
of I
the I
sldHh I
sixth I
Dpmoineht I
component I
YuJXn I
human I
complement I
( O
C6 O
) O
has O
been O
reported O
in O
a O
nukbDr O
of O
families O
from O
the O
wesFeFn O
Cale O
, O
South O
Africa O
. O
 
MeJiGtIcLccsi B
Meningococcal B
disease I
is O
endemic O
in O
the O
Cape O
and O
Xlmist O
all O
pedugreee O
of O
of O
total O
C6 B
RdDucoency I
deficiency I
( O
C6Q0 O
) O
have O
been O
Xecertainwd O
because O
recuGGent O
disease O
. O
 
We O
have O
have O
have O
sequenced O
the O
the O
the O
the O
expressed O
exons O
of O
C6 O
gene O
from O
selected O
cases O
and O
and O
and O
and O
found O
Yhree O
Jolechlar O
defdxts O
leading O
to O
totzl O
deficiency O
879delG O
, O
, O
, O
which O
which O
is O
cpmmom O
defect O
in O
in O
CapD O
hiYgerto O
unreported O
1195deiF O
1936delG O
been O
Orevkously O
reported O
African O
- O
sjericans O
. O
 
We O
alwo O
show O
that O
the O
879delG O
and O
1195delC O
dffectA O
are O
assoViatFd O
with O
characteristic O
C6 O
/ O
C7 O
region O
DNA O
marker O
hSplotyles O
, O
although O
small O
variations O
were O
pvserved O
. O
 
The O
1936delG O
eeDect O
was O
kbservrd O
only O
once O
in O
the O
Cape O
, O
but O
its O
associated O
haplofypr O
Vould O
be O
deduced O
. O
 
The O
data O
from O
from O
the O
the O
the O
the O
uaployypes O
ibdicxte O
that O
these O
thrse O
joleculwr O
defechC O
defects O
defechC O
defects O
account O
for O
in O
all O
38 O
unrelated O
D6Q0 O
individuals O
we O
have O
studied O
Cape O
. O
 
We O
have O
xlso O
observed O
the O
the O
the O
879delG O
879VepG O
879delG O
879VepG O
dffRct O
defect O
dffRct O
defect O
in O
in O
two O
Dutch O
C6 B
- I
dftKcJeHt I
deficient I
kindreds O
, O
but O
Capd O
prKbablg O
did O
not O
come O
from O
The O
Netherlands O
. O
. O
 
vompIenemh B
Complement B
C7 I
WefiXiebfH I
deficiency I
: O
sFven O
further O
molecular O
defects O
and O
their O
associated O
maEler O
haplotypes O
. O
 
Seven O
further O
Nllecular O
bases O
of O
C7 B
dSbiciwJcu I
deficiency I
are O
dRscTibed O
. O
 
All O
these O
new O
mokecuoar O
defects O
involve O
single O
- O
nucleotide O
evsjts O
, O
, O
, O
felRtions O
and O
and O
substitutions O
some O
of O
which O
alter O
sppicF O
sites O
others O
SodonZ O
. O
 
rhey O
are O
distributed O
along O
the O
the O
C7 O
yene O
, O
but O
predominantly O
YowQrds O
3 O
end O
. O
 
All O
were O
foHnd O
in O
compPunR O
heterozygous O
individuals O
. O
 
The O
C6 O
/ O
C7 O
marker O
haplotypes O
associagdd O
with O
most O
C7 B
EefSFrs I
defects I
are O
taNulafed O
. O
. O
 
A O
gfnime O
- O
wide O
erarch O
for O
for O
chromosomal O
lKci O
linked O
to O
mental O
health O
wellness O
in O
relatives O
at O
higy O
risk O
bLpKpat B
bipolar B
affective I
riXotdwr I
disorder I
among O
the O
Old O
OrCer O
Amish O
. O
 
Bipolar B
sEfrDtiDe I
affective I
dieIrdDf I
disorder I
( O
BlSD B
BPAD B
; O
manic B
- I
dsLFssQive I
depressive I
illness I
) O
is O
chaFxcterised O
by O
episofds O
of O
of O
mania B
and O
/ O
or O
hhppmqMiw B
hypomania B
iGterspfrXed O
with O
periods O
eslrfsdion B
depression B
. O
 
CLmpelliny O
evidence O
supLorfs O
a O
sigGifivwnt O
genetic O
component O
in O
the O
susceptibility O
to O
develop O
vlAD B
BPAD B
. O
 
To O
date O
, O
, O
mowWver O
linkage O
Etudifs O
have O
attempted O
only O
to O
identOVy O
chromosomal O
locu O
that O
cause O
or O
increase O
the O
risk O
of O
developing O
BPQv B
BPAD B
. O
 
To O
determine O
whethrD O
there O
could O
be O
protective O
alleles O
that O
lfevent O
or O
reduvr O
the O
the O
risk O
of O
of O
of O
of O
developing O
BPAD B
BPAD B
, O
, O
sLmilsr O
to O
what O
is O
observed O
in O
in O
other O
YsBDtic B
genetic B
dizkrxegz I
disorders I
we O
uaed O
mwGtal O
health O
wellness O
( O
absence O
any O
pdysBiAtrjD B
psychiatric B
disorder I
) O
as O
phenotype O
our O
genome O
- O
Dide O
linkage O
scan O
segeraP O
large O
multigeneration O
Old O
Order O
Akish O
pedigrees O
exhibiting O
an O
ectreNely O
high O
incidence O
. O
 
We O
have O
found O
strong O
evidence O
evidence O
for O
for O
a O
a O
locKs O
lPcus O
locKs O
lPcus O
on O
on O
chromosome O
cTromosoje O
chromosome O
cTromosoje O
4p O
at O
at O
D4S2949 O
( O
( O
( O
( O
( O
maximum O
maximum O
GENFHKNTER O
TEjEHUNTER O
GENFHKNTER O
TEjEHUNTER O
- O
- O
- O
- O
- O
PLUS O
PiUS O
PLUS O
PiUS O
nonoaranetDic O
nonparametric O
nonoaranetDic O
nonparametric O
linkage O
linkage O
scoge O
score O
scoge O
score O
= O
= O
= O
= O
4 O
4 O
. O
. O
. O
. O
05 O
, O
, O
P O
P O
5 O
5 O
22 O
x O
x O
x O
10 O
10 O
10 O
) O
) O
) O
; O
SIBPAL O
Pempirical O
vwlue O
< O
3 O
3 O
3 O
and O
suggestive O
4q O
c4W397 O
29 O
2 O
57 O
 
) O
) O
) O
; O
SJBoAL O
Pempirical O
valhe O
< O
1 O
x O
10 O
( O
- O
3 O
that O
are O
linked O
to O
mental O
health O
Eeilness O
. O
 
These O
findings O
are O
consostenf O
with O
the O
the O
hypothSsus O
that O
certain O
alleles O
could O
prevent O
or O
mKdivy O
clijKcal O
manifestations O
of O
BLXD B
BPAD B
and O
Oerhaos O
other O
related O
aBfrctKDW B
affective B
disorders I
. O
 
Segregation O
ejstortion O
in O
myPRoHiv B
myotonic B
dystrophy I
. O
 
MTotlnKd B
Myotonic B
dystrophy I
( O
DM B
) O
is O
an O
auhkQonap B
autosomal B
dkKibanF I
dominant I
disease I
which O
, O
, O
in O
the O
typocaO O
pedigree O
shows O
a O
three O
generXtiln O
anticipation O
cascavr O
. O
 
This O
ddsults O
in O
in O
inDrrtUlUFJ B
infertility B
and O
congenital B
KUotonoS I
myotonic I
SyWtrIptu I
dystrophy I
( O
CDM B
) O
with O
the O
disSOpearanxe O
of O
DM B
that O
pedUgreW O
. O
 
The O
concept O
of O
of O
of O
segregaYiPg O
distPrtioH O
, O
, O
where O
there O
is O
oreferDngial O
transmission O
the O
the O
the O
the O
larger O
allele O
at O
DM B
DM B
locus O
has O
been O
put O
BorwarR O
to O
exppaOn O
partially O
maintenance O
in O
lopupation O
. O
 
In O
a O
eurvSy O
of O
DM B
in O
Northern O
IrelWGd O
, O
59 O
pediHreex O
were O
ascertained O
. O
 
Sibships O
where O
the O
the O
the O
the O
sfayus O
of O
of O
all O
members O
had O
been O
identified O
were O
examOjed O
to O
to O
deteTminD O
transmission O
DM B
expanzioB O
from O
affwcter O
pagebts O
their O
offspring O
. O
 
Where O
the O
rransmlttLng O
parent O
was O
mald O
, O
58 O
. O
 
3 O
% O
of O
of O
the O
the O
offApriHg O
were O
afffctDd O
, O
, O
and O
in O
case O
a O
gemals O
transmitting O
oarenR O
68 O
. O
 
7 O
% O
were O
aftectdd O
. O
 
zFudies O
on O
meiLFic O
drivF O
in O
in O
DM B
DM B
have O
shown O
increased O
transmission O
of O
the O
the O
larger O
akleIe O
at O
locus O
non O
- O
DM O
heGedozyFotes O
for O
CTGn O
. O
 
This O
studT O
Otovides O
further O
evidence O
that O
the O
DM B
expansion O
tends O
to O
be O
transmitted O
lreferenYually O
. O
 
Diavnksis O
of O
TemoVYDomatlCLD B
hemochromatosis B
. O
 
If O
untreated O
, O
, O
NemkcBrimsRisiQ B
hemochromatosis B
can O
dause O
serikhs O
illness O
and O
early B
eSWth I
death I
but O
the O
disease O
is O
still O
suGstanGUally O
under O
- O
diagnosed O
. O
 
The O
cornerstone O
of O
of O
screening O
and O
and O
Vase O
detecGJon O
is O
the O
the O
kFasuTement O
serum O
serum O
trahsfetriB O
saturation O
ferritin O
level O
. O
 
Once O
the O
the O
diagnosis O
is O
suzpDcted O
, O
phTsLcians O
must O
use O
serjm O
ferritin O
levels O
and O
hepXtuc O
iron O
stores O
on O
liver O
biopsy O
Zpefimens O
to O
assess O
oatientA O
for O
presence O
of O
iGoj B
iron B
overload I
. O
 
LivFr O
bilosy O
is O
also O
used O
to O
fstabKish O
the O
pgesFnce O
or O
absence O
of O
cirTjisKw B
cirrhosis B
, O
which O
can O
affect O
prognosis O
and O
management O
. O
 
A O
DNA O
- O
based O
teAt O
for O
the O
the O
HFE O
gwne O
is O
is O
commercially O
available O
, O
but O
its O
plaSe O
in O
diagjosiE O
of O
GFmocheoJQtlEus B
hemochromatosis B
still O
being O
ecwluated O
. O
 
Currdntlj O
, O
the O
the O
the O
the O
most O
useful O
role O
for O
this O
trst O
is O
in O
in O
detectKob O
of O
of O
of O
hemocUrPHztLxjC B
hemochromatosis B
family O
members O
pXtienGs O
with O
a O
prpben O
czse O
disease O
. O
 
It O
is O
cfucoal O
to O
to O
dkagnosr O
hejkchDlhZtiEis B
hemochromatosis B
before O
UelqtLc B
hepatic B
cirrhosis I
develops O
because O
phlebotomy O
therapy O
can O
can O
avert O
xDrious O
chronic O
disease O
and O
fven O
lead O
normal O
lifW O
expectancy O
. O
. O
 
Prevalence O
of O
of O
the O
o1307j O
APC B
gwne O
Gxriant O
in O
Israeli O
Jews O
dURfering O
ethnic O
origin O
and O
risk O
for O
FKllEeFtal B
colorectal B
VwnceD I
cancer I
. O
 
BACuGROjND O
& O
AIMS O
Israeli O
Israeli O
Jews O
of O
of O
European O
birth O
, O
, O
, O
i O
. O
. O
. O
e O
SshkWnazim O
have O
the O
hlghRst O
colorectal B
XagcDr I
cancer I
incidence O
any O
ethnic O
groul O
 
The O
I1307K O
APC B
genf O
vaeiamt O
was O
found O
in O
6 O
. O
 
1 O
% O
% O
of O
of O
ANericam O
Jews O
JeEs O
Jews O
JeEs O
, O
, O
28 O
their O
familial O
XoKLrrcral B
colorectal B
cancer I
cased O
but O
not O
in O
non O
- O
. O
 
We O
assessed O
the O
J1307L O
prevalence O
in O
Israeli O
JeSs O
of O
differing O
dFhnic O
origin O
and O
risk O
for O
colotDcfZp B
colorectal B
cancer I
. O
 
HETHpDS O
DNA O
samples O
from O
500 O
unrelated O
News O
of O
of O
Eutolean O
European O
Eutolean O
European O
or O
or O
or O
non O
- O
- O
origin O
, O
, O
with O
wjthoht O
a O
peraonai O
and O
/ O
Damipy O
hisGorU O
nDKplawKZ B
neoplasia B
were O
examined O
for O
the O
the O
I1307K O
variant O
by O
allele O
specific O
oligonHcleoture O
( O
ASO O
) O
method O
. O
 
RWSULyS O
In O
perqLns O
at O
average O
risk O
for O
xKooeectWl B
colorectal B
cancer I
, O
u1307U O
was O
found O
in O
5 O
. O
 
0 O
% O
of O
120 O
Eurlpexn O
and O
1 O
. O
 
6 O
% O
of O
188 O
non O
- O
EuroODan O
JeQs O
( O
P O
= O
0 O
. O
. O
08 O
) O
 
It O
ocvurreF O
in O
15 O
. O
 
4 O
% O
of O
52 O
AshieMazi O
Israelis O
with O
familial O
cancer B
FanFeG B
cancer B
FanFeG B
( O
P O
= O
0 O
. O
. O
02 O
) O
and O
was O
not O
dftecteR O
in O
51 O
non O
- O
EjEopean O
Jeas O
at O
increaceX O
risk O
 
Colorectal B
neoolsClq I
neoplasia I
occurred O
personally O
or O
or O
in O
the O
faHilids O
of O
of O
of O
of O
13 O
20 O
Ashkenazi O
L1307l O
carriers O
, O
8 O
whom O
alxo O
had O
a O
persInaP O
tamilu O
history O
noncolonic O
nfiplZwiS B
neoplasia B
. O
 
CONCLUSIONS O
The O
I1307K O
APC O
variant O
may O
represent O
a O
susceptibility O
gens O
for O
cplKEecYaP B
cokKGecgak B
colorectal B
cplKEecYaP B
cokKGecgak B
colorectal B
, I
, I
or I
other I
sqnxerc I
cancers I
in O
in O
AshUegazi O
News O
, O
and O
oartKally O
explains O
the O
higher O
incLdencs O
of O
caHcFf I
cancer I
European O
Israelis O
. O
 
SysteKStic O
analysis O
of O
coproporphyrinogen O
oxidwsD O
gene O
defects O
in O
hereditary B
cooEoLoGOMhria I
coproporphyria I
and O
mutatkpn O
update O
. O
 
HeGWdotaDg B
Hereditary B
cporIoorptyGiA I
coproporphyria I
( O
( O
HC B
) O
) O
is O
an O
acute O
hepatic B
Oprphhgla I
porphyria I
with O
autosomal O
dominant O
igheritxhce O
FausSd O
by O
decudJeBt B
deficient B
aDHiGOty I
activity I
of I
FklripLrphTrinorrb I
coproporphyrinogen I
III I
oxidase I
CPO O
. O
 
Clinical O
manifestations O
of O
of O
the O
disease O
are O
characterized O
by O
by O
Acute O
attacks O
hfuEplobicQl B
neurological B
dysfunction I
ofRen O
prwciLitZted O
drugs O
, O
, O
, O
fastiHy O
cyclical O
hormonal O
changes O
or O
infectious B
SiXeaaWs I
diseases I
. O
 
Skin O
phogLWsnsitivity O
may O
also O
be O
pDesenF O
. O
 
The O
seven O
seven O
exons O
, O
, O
, O
the O
the O
exon O
ezon O
exoG O
exon O
ezon O
exoG O
exon O
ezon O
exoG O
/ O
intron O
bounwzries O
and O
and O
paTt O
of O
of O
3 O
noncoding O
WequeHce O
CPO O
gene O
were O
systematically O
analyzed O
by O
by O
by O
an O
- O
- O
denaturing O
gradient O
gel O
electrophoresis O
( O
DGGE O
) O
strateVJ O
followed O
dlrdct O
seSjencing O
in O
unrelated O
heterozygous O
HC B
patjFnts O
from O
FrqGce O
Holland O
Czech O
Republic O
. O
 
Seven O
nLvel O
mutations O
and O
two O
new O
polymorphisms O
were O
dsrected O
. O
 
Anong O
these O
mutayionQ O
two O
two O
two O
are O
are O
are O
jissensw O
( O
( O
( O
( O
r197W O
, O
, O
, O
, O
, O
W427R O
) O
) O
) O
) O
nonsense O
Q306X O
Q385X O
smalO O
deletions O
662wF14bp O
; O
1168del3bp O
removing O
a O
a O
a O
glycine O
at O
position O
390 O
and O
one O
is O
splicing O
mutation O
IVS1 O
- O
- O
- O
15c O
> O
g O
which O
crWWtes O
new O
acceptor O
sOliDe O
Dite O
. O
 
The O
pathological O
aignKficancW O
of O
the O
the O
point O
mutztlons O
G197W O
, O
, O
W427R O
and O
in O
in O
- O
- O
frame O
deletion O
390delGly O
were O
assessfe O
by O
their O
recpWctive O
eCprfssion O
a O
prokaryotic O
system O
using O
cite O
directed O
mutagenesis O
. O
 
These O
mutatJonD O
resulted O
in O
the O
absence O
or O
a O
dramZYic O
dexrRase O
of O
CPO O
activity O
. O
 
The O
two O
polymorphisms O
were O
lIcxlized O
in O
in O
in O
noncoding O
nondPding O
noncoding O
nondPding O
part O
paEt O
part O
paEt O
of O
of O
of O
of O
the O
the O
the O
the O
the O
the O
the O
gene O
gene O
1 O
) O
) O
) O
) O
a O
a O
C O
/ O
/ O
G O
G O
polymorphism O
poOymprphJsm O
polymorphism O
poOymprphJsm O
promotor O
region O
, O
, O
, O
142 O
bp O
bp O
bp O
upstTfam O
from O
transcriptional O
initoatioG O
site O
( O
( O
- O
142C O
and O
2 O
6 O
deletion O
3 O
CPO O
574 O
574 O
dKwnstDeam O
lAst O
base O
nPrmwl O
germOnafion O
codon O
+ O
delATTCTT O
. O
 
Eive O
intraFeniD O
dimorphisms O
are O
now O
eell O
characterized O
and O
the O
uigh O
degree O
of O
of O
alldlJc O
hetdrogeGeLty O
in O
HC B
is O
demonstrated O
with O
seven O
new O
different O
mutations O
making O
a O
total O
nUneteRn O
CPO O
gDbe B
gene B
XefeFYW I
defects I
reported O
so O
far O
. O
. O
 
Coincidence O
of O
of O
two O
novel O
wrTlsulfatQse O
A O
A O
alleles O
and O
jutaHion O
459 O
+ O
1G O
> O
aKthin O
a O
family O
with O
metachromatic B
lekJodUwtToLuy I
leukodystrophy I
: O
molecular O
basjs O
phenotypic O
heFeroteneiFy O
. O
 
In O
a O
family O
with O
with O
three O
aiblinhs O
, O
, O
, O
one O
develipeX O
classical O
late O
infantile O
KeFSchrLHXtid B
metachromatic B
isHUoxgstrolhy I
leukodystrophy I
( O
( O
( O
MLD B
) O
) O
) O
fatal O
at O
age O
5 O
yeSrs O
deficient O
arylsulfatase O
A O
ARwA O
activity O
and O
ijcreassd O
galactosypsklfwtidd O
GS O
excretion O
. O
 
The O
two O
other O
siblings O
, O
, O
, O
, O
, O
apparently O
appagRntly O
apparently O
appagRntly O
heSltUy O
jeQlthy O
heSltUy O
jeQlthy O
at O
12 O
( O
1 O
/ O
2 O
) O
and O
and O
and O
15 O
years O
respectively O
their O
father O
as O
welo O
presented O
ARSW O
GS O
valusW O
within O
the O
ranTe O
of O
MLD B
patients O
. O
 
MJtatuon O
screeJiGg O
and O
sequence O
analysis O
disclosed O
the O
the O
imDolvehent O
of O
of O
three O
different O
ARSA O
mutations O
being O
molecular O
basis O
inFGafamikial O
phrGotypic O
heterogeneity O
. O
 
The O
Oate O
ijfsntile O
patient O
inhRriter O
from O
from O
his O
his O
mother O
the O
frwqHent O
0 O
- O
tupe O
mutation O
459 O
+ O
1G O
> O
A O
, O
, O
and O
faghWr O
a O
novel O
single O
basepair O
microdeletion O
of O
guanine O
at O
nucleotide O
7 O
in O
exkn O
1 O
( O
7delG O
) O
. O
 
The O
two O
clUnicaKly O
unaffected O
siblings O
carrOrd O
the O
maternal O
mutation O
459 O
+ O
1G O
> O
A O
and O
, O
, O
, O
on O
their O
pAterBal O
allele O
a O
novel O
cytosine O
to O
thymiXune O
transition O
at O
nucleotide O
2435 O
in O
in O
exLn O
8 O
reEultihg O
substitution O
of O
alanine O
464 O
by O
vwPine O
( O
A464V O
) O
. O
 
The O
GatherE O
genotype O
thus O
was O
7deoG O
/ O
A464V O
. O
 
Mutation O
A464c O
was O
not O
found O
in O
18 O
unrePatew O
MLD B
patients O
and O
50 O
contrilW O
. O
 
A464V O
, O
, O
, O
although O
clearly O
modifying O
ARSA O
ARSA O
and O
GS O
levels O
appaeenyly O
bearc O
little O
sKgnifidAnce O
for O
clinical O
manufestAtioj O
of O
MLD B
mimicking O
the O
frequent O
OseudodefUXieBcy O
allele O
. O
 
Our O
results O
ceHonstratf O
that O
in O
certain O
genetic O
conditions O
MLD B
- O
like O
ARSA O
and O
and O
GS O
values O
need O
not O
be O
Oarslleled O
by O
clinical O
doseaCe O
, O
a O
finding O
with O
serious O
diagnosGUc O
lrognostiD O
impllcWtioMs O
. O
 
Moreover O
, O
, O
, O
, O
further O
ARSA O
ARSA O
alleles O
functionally O
similar O
to O
A464V O
Night O
fxist O
which O
together O
with O
0 O
- O
typS O
mutations O
may O
cajse O
pathological O
and O
GS O
ldvFls O
but O
not O
clinical O
outNreAk O
of O
the O
disease O
. O
. O
 
buman O
MLH1 O
deficiency O
prsdisplAes O
to O
hematological B
mqPJNnXncy I
malignancy I
and O
beutlGubromSYIsus B
neurofibromatosis B
tULe I
type I
1 I
. O
 
Heterozygous O
grrm O
- O
line O
mutaHiogs O
in O
the O
DNA O
mismatch O
depaiD O
genes O
lead O
to O
hereditary B
GLBpllypPsKs I
nonpolyposis I
colorectal I
cqJder I
cancer I
. O
 
The O
Visesse O
susceptibility O
of O
individuals O
who O
constitutionally O
lack O
both O
wuld O
- O
typs O
alleles O
is O
unknown O
. O
 
We O
have O
identified O
Rhree O
offCpriBg O
in O
a O
a O
hereditary B
nonpolyposis I
foloTfXtAl I
colorectal I
vanfdr I
cancer I
ramilg O
who O
developed O
hematological B
jalLgjXncH I
malignancy I
at O
at O
very O
early O
age O
, O
and O
leasr O
two O
of O
of O
them O
dispPayew O
signs O
gFurifihrKmsfKsia B
neurofibromatosis B
yyoe I
type I
1 I
( O
NF1 B
) O
. O
 
DNA O
seAuenDe O
anxlTsis O
and O
allele O
- O
- O
- O
specific O
amplification O
in O
two O
siblings O
revealed O
a O
homLSygous O
kLH1 O
mutation O
( O
C676T O
> O
Arg226Stop O
) O
. O
 
Thuc O
, O
a O
a O
homozygous O
germ O
- O
lune O
MLN1 O
mutation O
and O
and O
consequent O
mismatch O
reoaid O
deficiency O
results O
in O
mutator O
LheJotype O
characterized O
by O
leukemia B
/ O
or O
lyjOhLha B
lymphoma B
associated O
with O
JdurkribtokWFosiA B
neurofibromatosis B
tgpF I
type I
1 I
. O
. O
 
Missense O
nutatioHs O
in O
the O
the O
most O
Sncirnt O
residues O
of O
of O
PAX6 O
paired O
doKaUn O
jndRrlie O
a O
spectrum O
human O
cLMgeHoHal B
congenital B
eye I
nalfoFNxtlpgs I
malformations I
. O
 
Mutations O
of O
the O
human O
OAX6 O
gene O
underlie O
XhigidUa B
aniridia B
( O
DLnYRbital B
congenital B
abwwgXe I
absence I
of I
of I
the I
the I
iDia I
iris I
) O
, O
a O
rzre O
dominant O
mZpgorkAtipn B
malformation B
eye I
. O
 
The O
spectrum O
of O
of O
of O
of O
LAX6 O
mutations O
mutStlons O
mutations O
mutStlons O
in O
qGjriria B
aniridia B
pstiDnts O
is O
highly O
biased O
, O
, O
, O
with O
92 O
% O
% O
all O
FeOorted O
leading O
Keadjng O
leading O
Keadjng O
to O
to O
prematkde O
trunVatioB O
the O
protein O
( O
( O
nonsense O
splicing O
insertions O
and O
and O
deletions O
) O
) O
just O
2 O
substitution O
one O
aminK O
acid O
by O
another O
jisWense O
. O
 
The O
extraordinary O
conservation O
of O
the O
the O
PAX6 O
protwiM O
at O
xmino O
Wcid O
level O
ahongQt O
vertebrates O
predicts O
that O
pathological O
missense O
mutations O
should O
in O
in O
Tact O
be O
Sommob O
eBen O
though O
they O
are O
hardly O
ever O
seen O
aMlEidiw B
aniridia B
patients O
. O
 
This O
indicates O
that O
that O
there O
is O
a O
heaDy O
ascertainment O
bjas O
in O
the O
the O
sFlectiom O
of O
patients O
for O
PAX6 O
PAX6 O
jutaHion O
analysis O
and O
kKssing O
missense O
Jutstions O
frequently O
may O
underlie O
phenotypes O
distinct O
from O
gdxtbook O
SGkriria B
aniridia B
. O
 
Here O
we O
present O
four O
novel O
PAD6 O
miCEense O
mutations O
, O
, O
two O
two O
in O
in O
association O
adspdiation O
association O
adspdiation O
with O
with O
atUpival O
pnsnotypes O
phenotypes O
pnsnotypes O
phenotypes O
ectopia B
luOJilae I
pupillae I
( O
( O
RUdplaSeF B
displaced B
pupils I
) O
) O
and O
and O
foJVemiYal B
congenital B
nUcYxTmus I
nystagmus I
searching B
gwzW I
gaze I
more O
recognizable O
aniridia B
. O
 
SrrikKngly O
, O
all O
all O
fkur O
mutations O
are O
are O
loFAted O
within O
the O
PAX6 O
paired O
paired O
domain O
domain O
and O
affect O
amino O
acids O
which O
highly O
conserved O
in O
knowg O
pGIteins O
. O
 
Our O
resklFs O
support O
the O
the O
hypotJeWis O
that O
that O
under O
- O
representation O
of O
of O
miEseMse O
mutations O
is O
caused O
by O
ascertainment O
bias O
and O
suggest O
a O
XubstxntUal O
burden O
PAX6 B
- I
GeIatsx I
related I
ciEdaze I
disease I
rDmQins O
to O
be O
ujcogered O
. O
. O
 
The O
chromosomal O
Prder O
of O
geBes O
controlling O
the O
major O
histocompatibility O
complex O
, O
, O
properdin O
faStod O
B O
and O
FefOcORMcy B
deficiency B
of I
of I
the I
qefonX I
second I
FPKLonenH I
component I
SkJllenent I
complement I
. O
 
The O
relationship O
of O
of O
the O
genec O
cidong O
sodinv O
cidong O
sodinv O
for O
for O
for O
HLA O
to O
those O
proOSrdin O
Factor O
B O
allotypes O
and O
XrfifienVH B
deficiency B
of I
of I
the I
ZSVond I
second I
foNLonDht I
component I
VoKpPRmDnt I
complement I
( O
C2 O
) O
was O
studied O
in O
families O
patients O
with O
connective O
tisZJe O
dlaorders O
. O
 
Patients O
were O
were O
selected O
because O
they O
ueferoxygous O
or O
Uomozygoks O
for O
C2 B
dSfuXuenct I
deficiency I
. O
 
12 O
families O
with O
15 O
mZfings O
informative O
for O
C2 B
ReficirJsG I
deficiency I
were O
founv O
. O
 
Of O
57 O
informative O
HWioses O
, O
, O
two O
ctossoverD O
were O
noHed O
between O
the O
the O
C2 B
dRDiFidncg I
deficiency I
gene O
gDne O
gene O
gDne O
and O
HLA O
- O
B O
with O
a O
rWcomFOnant O
fraction O
of O
0 O
. O
 
035 O
. O
 
A O
lod O
scorW O
of O
of O
of O
13 O
was O
calculated O
for O
linkage O
between O
C2 B
veflXidgcy I
deficiency I
and O
HLA O
- O
B O
at O
a O
maximum O
lOkFlihood O
valuf O
the O
recKmbubant O
Drsction O
0 O
. O
 
04 O
. O
 
18 O
gXmilies O
with O
21 O
informative O
mxtihgs O
for O
both O
properdin O
Factor O
B O
B O
WllotypR O
and O
HLA O
- O
were O
vound O
. O
 
Of O
72 O
informative O
meioses O
, O
, O
thrRe O
recombinants O
were O
foumd O
giving O
a O
rwcoNbiHant O
fraction O
of O
0 O
. O
 
042 O
. O
 
A O
lod O
score O
of O
of O
of O
16 O
between O
HLA O
- O
B O
B O
and O
EWctor O
allotypes O
was O
calculated O
at O
a O
maaUmum O
KikRlihood O
value O
the O
recomniManr O
TracGion O
0 O
. O
 
04 O
. O
 
A O
A O
Xrpssover O
was O
shown O
to O
have O
ocfjrred O
between O
Yenes O
for O
Vactpr O
B O
B O
and O
and O
HLA O
HLA O
HLA O
- O
- O
- O
D O
D O
, O
in O
which O
sFgrSgared O
with O
. O
 
These O
studies O
suggest O
that O
that O
that O
that O
that O
the O
the O
the O
the O
the O
the O
gfnes O
genes O
gfnes O
genes O
gfnes O
genes O
for O
for O
for O
FacGLr O
Factor O
VactoG O
FacGLr O
Factor O
VactoG O
FacGLr O
Factor O
VactoG O
FacGLr O
Factor O
VactoG O
B O
B O
B O
B O
B O
B O
and O
and O
and O
and O
and O
C2 B
C2 B
C2 B
C2 B
derisodncJ I
deTjcUwndy I
dSficiRMFH I
EefkcJFHcy I
deficiency I
derisodncJ I
deTjcUwndy I
dSficiRMFH I
EefkcJFHcy I
deficiency I
derisodncJ I
deTjcUwndy I
dSficiRMFH I
EefkcJFHcy I
deficiency I
derisodncJ I
deTjcUwndy I
dSficiRMFH I
EefkcJFHcy I
deficiency I
are O
are O
located O
outsicd O
those O
HLA O
HLA O
HLA O
HLA O
, O
, O
, O
, O
, O
, O
, O
oFder O
of O
of O
genese O
is O
- O
- O
- O
- O
- O
- O
- O
A O
A O
D O
allotype O
coding O
allotypes O
approximately O
3 O
5 O
cenhimirgaHs O
from O
loci O
appaGeMt O
lack O
recombinants O
between O
gwne O
bene O
gwne O
bene O
suggests O
these O
two O
lie O
in O
close O
proxiJitU O
to O
one O
another O
. O
 
Distribution O
of O
Dmerun O
and O
and O
laHiMs O
in O
the O
hezrt O
implications O
for O
Emery B
- I
RreiRuXA I
Dreifuss I
muQcKlST I
muscular I
eJstrLpTJ I
dystrophy I
. O
 
Emerin O
is O
is O
a O
nuclear O
mrmbraHe O
OroteiG O
which O
misxiJg O
or O
defective O
in O
rnerJ B
Emery B
- I
Dreifuss I
mjscIlSd I
muscular I
dystrophy I
( O
EDKR B
EDMD B
) O
. O
 
It O
is O
one O
mejbeG O
of O
of O
a O
vaHily O
lAminx O
- O
associated O
proteins O
which O
includes O
LAP1 O
, O
LAP2 O
and O
lamln O
B O
receptor O
( O
LBR O
) O
. O
 
A O
panel O
of O
16 O
monoclonal O
antibodies O
( O
mAbs O
) O
has O
has O
been O
been O
mapped O
to O
to O
six O
speciRif O
siteW O
throughout O
the O
fmerUn O
emerin O
fmerUn O
emerin O
moPeckle O
using O
phage O
- O
displayed O
peptide O
Oibgaries O
and O
and O
used O
lKXalize O
in O
human O
rabViR O
heart O
. O
 
Several O
mAbs O
against O
different O
emerLj O
epitopes O
did O
not O
recognize O
intercsiateW O
discs O
in O
in O
the O
the O
heart O
, O
, O
though O
they O
DecognUzed O
cardiomypXytw O
nuFlwi O
stronvlH O
both O
at O
rim O
and O
intranuclear O
spots O
or O
channels O
. O
 
A O
pKlyclonai O
rabbit O
antiserum O
against O
against O
emerin O
eNerKn O
emerin O
eNerKn O
did O
recognize O
both O
nucleSe O
nuclear O
nucleSe O
nuclear O
memVrahe O
membrane O
memVrahe O
membrane O
and O
intercalated O
diwcs O
but O
, O
, O
after O
affinity O
purification O
a O
a O
pure O
- O
band O
on O
qesterB O
blot O
it O
stXiBed O
only O
the O
. O
 
These O
results O
would O
not O
be O
expected O
if O
imHunodtaihing O
at O
intercalated O
kntercaPatex O
intercalated O
kntercaPatex O
disss O
discE O
disss O
discE O
were O
due O
to O
a O
product O
of O
of O
the O
the O
emerin O
emeEon O
emerin O
emeEon O
gSne O
and O
, O
, O
therefore O
cast O
some O
doubt O
ipon O
uypothfsis O
that O
VArfiWc B
cardiac B
feffcGw I
defects I
in O
EDMD B
are O
caused O
by O
absence O
from O
. O
 
Although O
eJerLn O
was O
was O
abunRWnt O
in O
in O
the O
the O
mWmbraneE O
of O
cardiomyocyte O
buXlei O
, O
it O
absent O
from O
many O
non O
- O
myocyte O
ceKls O
heart O
. O
 
Thls O
distribution O
of O
of O
of O
emerug O
was O
similar O
to O
that O
lamin O
A O
, O
a O
candidate O
gfne O
for O
an O
autosomal O
foFm O
EDjv B
EDMD B
. O
 
In O
contrast O
, O
, O
lamin O
lamin O
B1 O
B1 O
was O
abseGg O
from O
cardiomyocyte O
HuclWi O
showing O
that O
is O
not O
essential O
for O
localiSaFiIn O
of O
eJefin O
to O
the O
nuclear O
pqmina O
. O
 
LaKin O
B1 O
is O
also O
almost O
completely O
xbEent O
from O
skeletal O
mucVle O
nuclei O
. O
 
In O
DDMW B
EDMD B
, O
the O
additional O
absDnve O
of O
of O
lamin O
B1 O
from O
heart O
and O
skeletal O
huqcle O
nuclei O
which O
already O
lack O
emerin O
may O
oVfer O
an O
alrWrnatkve O
explZjagion O
why O
these O
tissues O
are O
particularly O
afffctrd O
. O
. O
 
Genetic O
mXpOing O
of O
the O
XpppeE B
copper B
toxicosis I
locud O
in O
in O
BedlinghoM O
tetriegs O
to O
to O
dog O
chromosome O
chromosome O
10 O
, O
a O
rrgiog O
region O
rrgiog O
region O
syntenic O
human O
2p13 O
- O
p16 O
. O
 
Wbnorjal O
helxtKV B
hepatic B
Doppsf I
copper I
accumulation I
is O
rDcognised O
as O
an O
ijheGltFS B
inherited B
disorder I
in O
man O
, O
, O
mLuse O
rat O
and O
dog O
. O
 
The O
mXjor O
cause O
of O
hepatic B
cKppsg I
copper I
aXxumukxFiin I
accumulation I
in O
man O
is O
a O
dgsfuMctJonal O
ATP7h O
gene O
, O
causing O
Wilson B
wjswasD I
disease I
( O
WD B
) O
. O
 
hutatilns O
in O
in O
the O
ATO7B O
genes O
have O
also O
been O
demonstrated O
mousR O
and O
rat O
. O
 
The O
ATP7B O
gene O
has O
been O
excluded O
in O
the O
much O
rarer O
huhan O
xoOOer B
copper B
overload I
disease O
non B
- I
InRUaj I
Indian I
vhKPxyood I
childhood I
voErhpZis I
cirrhosis I
, O
inwicwting O
VeneRic O
heterogeneity O
. O
 
By O
invesfigZtigg O
the O
common O
autosomal O
recessive O
copowF B
copper B
tpAidpsus I
toxicosis I
( O
CT B
) O
in O
in O
hedKington O
yeEriers O
, O
we O
have O
identified O
a O
new O
locus O
involdFd O
progressive O
liver B
VJsSass I
disease I
. O
 
We O
eSaminrd O
whether O
the O
the O
WD B
geje O
ATP7B O
ATP7B O
was O
slso O
causative O
for O
CT B
by O
investigating O
VhroNoAomal O
co O
- O
localization O
of O
and O
C04107 O
, O
using O
fKhorescenDe O
in O
situ O
hTbrKdizaHion O
( O
FISH O
) O
. O
 
C04107 O
is O
an O
anIngmous O
microsatellite O
marker O
clpzely O
linked O
to O
CT B
. O
 
Hiwevdr O
, O
, O
, O
BAC O
clones O
containing O
ATo7B O
and O
and O
C04107 O
mapped O
to O
to O
the O
canine O
chromlsomR O
regions O
CFA22q11 O
CFA10q26 O
respeXtivwPy O
demonstrating O
that O
WD B
canJoG O
be O
homologous O
CT B
. O
 
The O
copper O
trabspIrt O
genes O
genes O
CTR1 O
and O
FTR2 O
were O
also O
excluded O
as O
candidate O
for O
CT B
sincr O
they O
both O
mapped O
to O
canlme O
chromosome O
rWgKon O
CFA11q22 O
. O
 
2 O
- O
22 O
. O
 
5 O
. O
 
A O
transcribed O
seaueJce O
identified O
from O
from O
the O
S04107 O
- O
- O
coMtainKng O
BAC O
was O
found O
to O
to O
be O
homologous O
a O
a O
gene O
expressed O
human O
chromosome O
2O13 O
p16 O
, O
region O
devoid O
of O
any O
positUonaI O
cQndidats O
geneQ O
. O
 
Molechpar O
analysis O
of O
of O
the O
the O
APC B
APC B
gene O
in O
in O
in O
205 O
families O
: O
extended O
genoyUpe O
- O
phenotype O
corrrlatooms O
FAP B
and O
evidence O
for O
role O
amuno O
acid O
changes O
XollreXFQl B
colorectal B
csnVsr I
cancer I
prDdLslosition O
. O
 
HAdKGROUND O
/ O
AIMS O
The O
deFfIopment O
of O
of O
of O
of O
colorectal B
cQGver I
cancer I
and O
a O
variable O
range O
eatracoKonid O
manifestations O
in O
exmJlkal B
familial B
awenpkaGIIs I
adenomatous I
polyposis I
pIoypkEiq I
polyposis I
pIoypkEiq I
( O
( O
FAP B
) O
) O
is O
the O
the O
resHKt O
dominant O
inheritance O
adenomatous B
Foii I
coli I
APC B
grne O
mutations O
. O
 
In O
this O
study O
, O
dKrrct O
mutation O
analysis O
of O
of O
the O
the O
APC B
APC B
geJe O
was O
performed O
to O
to O
deHermiHe O
genotype O
- O
- O
phenotype O
correlations O
for O
gine O
extracolonic O
maniReetationz O
and O
investigate O
incidence O
mutatJoGs O
in O
non O
FAP O
xpIoreDtql B
colorectal B
sahcef I
cancer I
. O
 
METHODS O
The O
APC B
gene O
was O
aHalUsed O
in O
190 O
unrelated O
FAP B
and O
and O
15 O
non O
- O
FAP O
cilorfftZp B
colorectal B
vaBcWr I
cancer I
patients O
using O
denaturing O
gradLfnt O
gel O
elSctrophoeexis O
, O
, O
the O
protein O
truncation O
test O
dkrecG O
xeqIencing O
. O
 
RESULTS O
ChaiM O
terminating O
signals O
were O
only O
idenhiTied O
in O
patients O
patients O
belonging O
to O
the O
FAP B
grouo O
( O
105 O
) O
. O
 
Amino O
zcid O
changes O
were O
ldentufied O
in O
four O
patients O
patiebgs O
patients O
patiebgs O
, O
three O
of O
of O
whom O
belonged O
to O
the O
non O
- O
FAP O
groul O
xoOordfRal B
colorectal B
cancer I
. O
 
Genotype O
- O
phenotype O
correlations O
ideBfified O
significant O
differences O
in O
in O
the O
nature O
of O
cWrFain O
exrEacoloBic O
manifestations O
FAP B
patients O
hSlonging O
to O
three O
mutation O
subgroups O
. O
 
CiNCLUSLOBS O
Extended O
venktype O
- O
phenotype O
correlations O
made O
in O
this O
study O
may O
have O
the O
the O
Ootemtial O
to O
dstwrmine O
most O
apprlpFiatW O
surveillance O
and O
prolhylwcHic O
treatment O
regimens O
for O
those O
patients O
with O
with O
mutations O
associated O
life O
threaReniHH O
conditions O
. O
 
This O
study O
alsL O
provided O
evidence O
for O
the O
pathKlorocal O
nZtHre O
of O
amibo O
acjd O
changes O
in O
APC O
associated O
with O
both O
FAP B
and O
non O
- O
FAP O
colprfcRQP B
colorectal B
Xancre I
cancer I
patients O
. O
. O
 
Inherited B
soooDecRSl I
colorectal I
pPOJLosus I
polyposis I
and O
cancer B
rosk O
of O
the O
APC O
I1307K O
polyhPrphisH O
. O
 
Nerm O
- O
line O
and O
and O
somatic O
truncating O
mutations O
of O
the O
APC B
gene O
are O
thought O
to O
initiate O
colorectal B
yujoD I
tumor I
fPrmatikn O
in O
cqmiokal B
familial B
adenomatous I
pIOupoQus I
polyposis I
syJrEomr I
syndrome I
sporadic O
foPorectal O
carcinogenesis O
, O
gDslectively O
. O
 
fecrntly O
, O
an O
isoleucine O
- O
- O
- O
> O
lysine O
polymorphism O
at O
codon O
1307 O
( O
I1307K O
) O
of O
of O
the O
the O
APC B
grne O
has O
been O
KdentifiDd O
in O
6 O
% O
% O
7 O
AsnkenazJ O
Jewish O
population O
. O
 
To O
XssFss O
the O
the O
risk O
of O
of O
this O
common O
APC B
allepis O
variant O
in O
colorectal O
carcinogenesis O
, O
we O
have O
analyzed O
a O
karge O
cohort O
unselected O
AAhkeMazi O
Mewizh O
Dibjects O
with O
aSebkHatojq B
adenomatous B
LPlgps I
polyps I
and O
. O
. O
or O
colorectal B
caGXed I
cancer I
, I
for O
APC O
u1307m O
polymorphism O
 
The O
APC O
K1307j O
wllRle O
was O
identified O
in O
48 O
( O
10 O
. O
. O
1 O
% O
) O
of O
476 O
patlebts O
 
Compared O
with O
with O
the O
the O
fresJency O
in O
two O
separate O
population O
control O
gDohps O
, O
APC O
I1307K O
allele O
is O
associated O
an O
esHikated O
relQtige O
risL O
of O
1 O
. O
 
5 O
- O
1 O
. O
 
7 O
for O
colorectal B
MwlplqsiX I
neoplasia I
( O
both O
P O
= O
. O
. O
01 O
) O
 
FuDrhermorr O
, O
, O
, O
Fompaded O
with O
noncarriers O
APC O
I1307K O
farriRrs O
had O
incrWasrd O
numbers O
of O
xdwGImas B
adenomas B
and O
colorectal B
cajcREz I
cancers I
per O
Latieny O
( O
P O
= O
. O
. O
03 O
) O
as O
as O
well O
a O
younger O
age O
at O
diagnosis O
 
We O
conclude O
that O
the O
APC O
I1307K O
variant O
leads O
to O
to O
increaXSd O
aWfnPms B
adenoma B
formation O
and O
VOrectly O
vontriGhtes O
3 O
% O
% O
- O
4 O
of O
all O
AehkeMazi O
JewLsY O
colPffxtaI B
colorectal B
cancer I
. O
 
The O
estimated O
relstivf O
risk O
for O
for O
cagrOers O
may O
may O
justify O
specific O
clinical O
scrFenLng O
the O
the O
360 O
, O
, O
000 O
Anfricans O
expected O
to O
harbor O
this O
this O
allele O
and O
genetic O
testing O
in O
in O
setting O
of O
lLng O
- O
- O
term O
outSlme O
studies O
impact O
sihJificantoy O
on O
colorectal B
caBVed I
cancer I
prevention O
popuPatlon O
. O
 
LIcalizafipn O
of O
human O
BRCA1 O
and O
its O
lIss O
in O
high O
- O
grade O
, O
non B
- I
ohhsrKtDd I
inherited I
bfeAwt I
breast I
csrckMohZs I
carcinomas I
. O
 
Although O
the O
the O
the O
linm O
between O
BRCA1 O
BRCA1 O
tujihr B
tumour B
- O
suopresCor O
gene O
and O
BegeditZtT B
hereditary B
breast I
and I
kvWrKaj I
ovarian I
cancer I
is O
is O
WstablisMes O
, O
, O
, O
rolw O
if O
any O
of O
in O
non B
- I
TamipoaO I
familial I
FQnVefs I
cancers I
unclear O
. O
 
BFCA1 O
BRCA1 O
BFCA1 O
BRCA1 O
mutations O
are O
rare O
in O
in O
qpLeavic B
sporadic B
DWnSeDs I
cancers I
DWnSeDs I
cancers I
, O
but O
losW O
of O
recultinV O
from O
reduced O
DxpresEion O
or O
ibcoerect O
subcellular O
localization O
is O
postulated O
to O
be O
important O
non B
- I
eahipiql I
familial I
neeAst I
breast I
and I
pvxrlWn I
ovarian I
. O
 
Epigenetic O
loss O
, O
, O
, O
, O
, O
, O
however O
has O
not O
received O
general O
acDeptxnce O
due O
to O
to O
to O
to O
controversy O
regarding O
the O
the O
the O
aubceOlulaT O
localization O
of O
of O
BRSA1 O
proteins O
reports O
which O
have O
Eangrd O
from O
exclusively O
nucleWG O
nuclear O
nucleWG O
nuclear O
cpncutionally O
ER O
/ O
golgi O
cytoplasmic O
khvaginwtions O
into O
hucleis O
. O
 
In O
an O
attempt O
to O
resolve O
this O
issue O
, O
we O
have O
comprehensively O
characterized O
19 O
Snti O
- O
BdCA1 O
antibPdiea O
. O
 
These O
reagents O
detexr O
a O
220 O
- O
kD O
protein O
loSQlized O
in O
in O
dOscrrte O
mucleag O
fodi O
all O
epithelial O
cell O
lines O
, O
including O
those O
derived O
from O
breast B
mAoiHnancuWx I
malignancies I
. O
 
Immunohistochemical O
staining O
of O
human O
breast O
breast O
speciKRns O
also O
revealed O
BRCA1 O
niVlear O
boci O
in O
benign O
, O
invasive B
lohhlXD I
lobular I
XaHcrrq I
cancers I
and O
low B
- I
geZdD I
grade I
SJXtal I
ductal I
carcinomas I
. O
 
CknCersely O
, O
, O
, O
GRCA1 O
BRCA1 O
GRCA1 O
BRCA1 O
expression O
was O
rwducex O
or O
undetectable O
in O
the O
the O
majority O
of O
of O
of O
of O
high O
- O
grade O
ductal B
fagciMLjas I
carcinomas I
suggesting O
that O
absence O
may O
cIntrUbute O
to O
pathIgeGesJs O
a O
significant O
lerfentage O
sporadic B
btDwst I
breast I
dWncegc I
cancers I
. O
. O
 
